{"recordsFiltered":48523,"recordsTotal":48523,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=30300","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=29700","results":[{"registry_id":"NCT05869773","publication_url":"https://clinicaltrials.gov/study/NCT05869773","title":"An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV","has_exemption":false,"start_date":"2023-06-26","completion_date":"2025-02-25","has_results":false,"results_due":true,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05978739","publication_url":"https://clinicaltrials.gov/study/NCT05978739","title":"A Randomized,Open-label, Multicenter, Phase II Trial Evaluating Two Different Doses of Orelabrutinib in Mantle Cell Lymphoma","has_exemption":false,"start_date":"2023-08-18","completion_date":"2025-02-25","has_results":false,"results_due":true,"sponsor_name":"InnoCare Pharma Inc.","sponsor_slug":"innocare-pharma-inc","status":"overdue","is_pact":false,"days_late":56},{"registry_id":"NCT06091410","publication_url":"https://clinicaltrials.gov/study/NCT06091410","title":"Immunogenicity of Concomitant Administration of Omicron-containing COVID-19 Vaccines With Influenza Vaccines : In-depth Immunogenicity Analysis.","has_exemption":false,"start_date":"2023-09-25","completion_date":"2025-02-25","has_results":false,"results_due":true,"sponsor_name":"Catholic Kwandong University","sponsor_slug":"catholic-kwandong-university","status":"overdue","is_pact":false,"days_late":56},{"registry_id":"NCT05997277","publication_url":"https://clinicaltrials.gov/study/NCT05997277","title":"A Pilot Study Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo in the Treatment of Moderate-to-severe Hidradenitis Suppurativa (HS).","has_exemption":false,"start_date":"2023-11-30","completion_date":"2025-02-25","has_results":false,"results_due":true,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT07102602","publication_url":"https://clinicaltrials.gov/study/NCT07102602","title":"Feasibility of Assessing Muscle Displacement and Muscle Excursion on Muscle Fatigue, With and Without Preventive Strategies","has_exemption":false,"start_date":"2024-11-30","completion_date":"2025-02-25","has_results":false,"results_due":true,"sponsor_name":"National Taiwan University Hospital","sponsor_slug":"national-taiwan-university-hospital","status":"overdue","is_pact":false,"days_late":56},{"registry_id":"NCT06817785","publication_url":"https://clinicaltrials.gov/study/NCT06817785","title":"Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere","has_exemption":false,"start_date":"2025-01-24","completion_date":"2025-02-25","has_results":false,"results_due":true,"sponsor_name":"Coopervision, Inc.","sponsor_slug":"coopervision-inc","status":"overdue","is_pact":false,"days_late":56},{"registry_id":"NCT03944941","publication_url":"https://clinicaltrials.gov/study/NCT03944941","title":"Phase II Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma of the Skin (cSCC)","has_exemption":false,"start_date":"2019-06-17","completion_date":"2025-02-26","has_results":false,"results_due":true,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04092894","publication_url":"https://clinicaltrials.gov/study/NCT04092894","title":"Effects of the Orexin Receptor Antagonist Suvorexant on Sleep Architecture and Delirium in the Intensive Care Unit: A Multi-Centric Randomized Controlled Trial","has_exemption":false,"start_date":"2020-02-28","completion_date":"2025-02-26","has_results":true,"results_due":true,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04182620","publication_url":"https://clinicaltrials.gov/study/NCT04182620","title":"Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation: A Pilot Study","has_exemption":false,"start_date":"2020-07-08","completion_date":"2025-02-26","has_results":false,"results_due":true,"sponsor_name":"Vivek Reddy","sponsor_slug":"vivek-reddy","status":"overdue","is_pact":false,"days_late":55},{"registry_id":"NCT04475939","publication_url":"https://clinicaltrials.gov/study/NCT04475939","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants Whose Disease Has Remained Stable or Responded to First-Line Platinum -Based Chemotherapy With Pembrolizumab for Stage IIIB/IIIC or IV Non-Small Cell Lung Cancer (ZEAL-1L)","has_exemption":false,"start_date":"2020-10-26","completion_date":"2025-02-26","has_results":false,"results_due":true,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05202262","publication_url":"https://clinicaltrials.gov/study/NCT05202262","title":"A Randomized, Double-Blind, Parallel Group, Multicenter 24 Week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler and Open-Label Symbicort® Turbuhaler® in Participants With Inadequately Controlled Asthma (VATHOS).","has_exemption":false,"start_date":"2022-01-12","completion_date":"2025-02-26","has_results":true,"results_due":true,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05211947","publication_url":"https://clinicaltrials.gov/study/NCT05211947","title":"An Open Label, Single Arm, Extension Trial to Examine Long-term Safety of Iclepertin Once Daily in Patients With Schizophrenia Who Have Completed Previous Iclepertin Phase III Trials (CONNEX-X)","has_exemption":false,"start_date":"2022-03-21","completion_date":"2025-02-26","has_results":true,"results_due":true,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05864365","publication_url":"https://clinicaltrials.gov/study/NCT05864365","title":"An Open-Label Biomarker Study of ATH434 in Multiple System Atrophy","has_exemption":false,"start_date":"2023-05-23","completion_date":"2025-02-26","has_results":false,"results_due":true,"sponsor_name":"Alterity Therapeutics","sponsor_slug":"alterity-therapeutics","status":"overdue","is_pact":false,"days_late":55},{"registry_id":"NCT05914311","publication_url":"https://clinicaltrials.gov/study/NCT05914311","title":"Use of Dermabond in Mitigation of Spinal Cord Stimulation Trial Lead Migration","has_exemption":false,"start_date":"2023-09-08","completion_date":"2025-02-26","has_results":false,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported-late","is_pact":false,"days_late":7},{"registry_id":"NCT06177912","publication_url":"https://clinicaltrials.gov/study/NCT06177912","title":"A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Children and Adolescents With Increased Risk of Pneumococcal Disease","has_exemption":false,"start_date":"2024-01-18","completion_date":"2025-02-26","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06280235","publication_url":"https://clinicaltrials.gov/study/NCT06280235","title":"A Phase II, 6-week, Multicenter, Randomized, Double Blind (Patient and Investigator) or Masked, Placebo Controlled, Dose-finding Trial to Evaluate the Efficacy, Tolerability, and Safety of Different Doses of Oral BI 1569912 as Adjunctive Therapy in MD","has_exemption":false,"start_date":"2024-03-27","completion_date":"2025-02-26","has_results":true,"results_due":true,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06357832","publication_url":"https://clinicaltrials.gov/study/NCT06357832","title":"A Prospective, Randomized, Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Deep Transcranial Magnetic Stimulation (Deep TMS) With a New Stimulation Protocol in Subjects With Major Depression Disorder (MDD)","has_exemption":false,"start_date":"2024-04-29","completion_date":"2025-02-26","has_results":false,"results_due":true,"sponsor_name":"Brainsway","sponsor_slug":"brainsway","status":"overdue","is_pact":false,"days_late":55},{"registry_id":"NCT06378086","publication_url":"https://clinicaltrials.gov/study/NCT06378086","title":"A Randomized, Controlled, Double-blinded, Within-subject (Split-face), Multicenter, Prospective Clinical Study to Compare the Level of Pain Using the Dermal Filler RHA® Redensity Formulated With Two Different Anesthetics in the Treatment of Perioral Rhytids","has_exemption":false,"start_date":"2024-06-11","completion_date":"2025-02-26","has_results":false,"results_due":true,"sponsor_name":"Teoxane SA","sponsor_slug":"teoxane-sa","status":"overdue","is_pact":false,"days_late":55},{"registry_id":"NCT06450405","publication_url":"https://clinicaltrials.gov/study/NCT06450405","title":"Androgen Effects on the Reproductive Neuroendocrine Axis","has_exemption":false,"start_date":"2025-02-26","completion_date":"2025-02-26","has_results":true,"results_due":true,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03193190","publication_url":"https://clinicaltrials.gov/study/NCT03193190","title":"A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)","has_exemption":false,"start_date":"2017-07-05","completion_date":"2025-02-27","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03409614","publication_url":"https://clinicaltrials.gov/study/NCT03409614","title":"A Two-Part Randomized, Phase 3 Study of Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in First-line Treatment of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2018-03-06","completion_date":"2025-02-27","has_results":false,"results_due":true,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03878199","publication_url":"https://clinicaltrials.gov/study/NCT03878199","title":"A Phase I/II, Open-Label, Multi-Center Study Evaluating the Safety and Efficacy of Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms","has_exemption":false,"start_date":"2019-02-20","completion_date":"2025-02-27","has_results":false,"results_due":true,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03906227","publication_url":"https://clinicaltrials.gov/study/NCT03906227","title":"Tailoring Maintenance Therapy to CD5+ Regulatory B Cell Recovery in ANCA Vasculitis","has_exemption":false,"start_date":"2019-06-28","completion_date":"2025-02-27","has_results":true,"results_due":true,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04323189","publication_url":"https://clinicaltrials.gov/study/NCT04323189","title":"Effects of Sitagliptin in Individuals With Genetically Decreased DPP4","has_exemption":false,"start_date":"2020-08-26","completion_date":"2025-02-27","has_results":false,"results_due":true,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"overdue","is_pact":false,"days_late":54},{"registry_id":"NCT04902040","publication_url":"https://clinicaltrials.gov/study/NCT04902040","title":"An Open-label, Single-Center, Phase 1b/2 Study to Evaluate the Safety of Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Malignancies After Progression on PD-1 or PD-L1 Targeted Antibodies","has_exemption":false,"start_date":"2021-04-14","completion_date":"2025-02-27","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05586009","publication_url":"https://clinicaltrials.gov/study/NCT05586009","title":"Comparative Study of Different Doses of Magnesium as a Protective Agent in Cisplatin Induced Nephrotoxicity in Patients With Head and Neck Cancer","has_exemption":false,"start_date":"2022-10-01","completion_date":"2025-02-27","has_results":false,"results_due":true,"sponsor_name":"Tanta University","sponsor_slug":"tanta-university","status":"overdue","is_pact":false,"days_late":54},{"registry_id":"NCT05704738","publication_url":"https://clinicaltrials.gov/study/NCT05704738","title":"A Phase 3, Randomized, 52-week, Placebo-controlled, Double-blind Study With Re-randomization to Assess the Efficacy, Safety, and Tolerability of Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASTRO)","has_exemption":true,"start_date":"2023-04-20","completion_date":"2025-02-27","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05545735","publication_url":"https://clinicaltrials.gov/study/NCT05545735","title":"Duration of Antibiotic Therapy for Early (DATE) Ventilator-Associated Pneumonia (VAP) Trial: A Surgical Infection Society Multicenter Randomized Clinical Trial of 4 vs. 7 Days of Definitive Antibiotic Therapy for Early VAP","has_exemption":false,"start_date":"2023-05-08","completion_date":"2025-02-27","has_results":true,"results_due":true,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06150924","publication_url":"https://clinicaltrials.gov/study/NCT06150924","title":"A Randomized, Crossover, Double Blind, Placebo Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors, in Adults With Hypertension and Chronic Kidney Disease With Albuminuria","has_exemption":false,"start_date":"2023-12-14","completion_date":"2025-02-27","has_results":false,"results_due":true,"sponsor_name":"Mineralys Therapeutics Inc.","sponsor_slug":"mineralys-therapeutics-inc","status":"overdue","is_pact":false,"days_late":54},{"registry_id":"NCT06493604","publication_url":"https://clinicaltrials.gov/study/NCT06493604","title":"A Randomized, Double-Masked, Vehicle-Controlled Parallel Group Clinical Trial to Assess Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease","has_exemption":true,"start_date":"2024-06-24","completion_date":"2025-02-27","has_results":false,"results_due":false,"sponsor_name":"Aldeyra Therapeutics, Inc.","sponsor_slug":"aldeyra-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06621017","publication_url":"https://clinicaltrials.gov/study/NCT06621017","title":"A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Daily Administrations of the GLP-1 Analogue ROSE-010 on Appetite and Food Intake in Overweight and Obese Subjects","has_exemption":false,"start_date":"2024-09-26","completion_date":"2025-02-27","has_results":false,"results_due":true,"sponsor_name":"Rose Pharma Inc","sponsor_slug":"rose-pharma-inc","status":"reported-late","is_pact":false,"days_late":46},{"registry_id":"NCT07511998","publication_url":"https://clinicaltrials.gov/study/NCT07511998","title":"A Randomized, Comparative, Controlled Study of Differences in the Incidence of Postoperative Sore Throat (POST) by Inner Diameter Size of the TaperGuardTM Endotracheal Tube (ETT)","has_exemption":false,"start_date":"2025-02-26","completion_date":"2025-02-27","has_results":false,"results_due":true,"sponsor_name":"Kyungpook National University Chilgok Hospital","sponsor_slug":"kyungpook-national-university-chilgok-hospital","status":"overdue","is_pact":false,"days_late":54},{"registry_id":"NCT00408447","publication_url":"https://clinicaltrials.gov/study/NCT00408447","title":"Allogeneic Stem Cell Transplant to Induce Mixed Donor Chimerism in Patients With Sickle Cell Disease and Thalassemia","has_exemption":false,"start_date":"2004-09-30","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"overdue","is_pact":true,"days_late":53},{"registry_id":"NCT01750567","publication_url":"https://clinicaltrials.gov/study/NCT01750567","title":"A Phase II Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia and Untreated CLL Patients With Genomic Deletion 11q","has_exemption":false,"start_date":"2012-11-30","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"reported-late","is_pact":true,"days_late":6},{"registry_id":"NCT02286557","publication_url":"https://clinicaltrials.gov/study/NCT02286557","title":"Testing the Effects of Methylphenidate on Cognitive Fatigue in Multiple Sclerosis: a Double-blind, Placebo-controlled, Randomized Clinical Trial","has_exemption":false,"start_date":"2014-10-31","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Kessler Foundation","sponsor_slug":"kessler-foundation","status":"overdue","is_pact":true,"days_late":53},{"registry_id":"NCT03065972","publication_url":"https://clinicaltrials.gov/study/NCT03065972","title":"A Randomized Controlled Comparative Study on Efficacy and Cost-effectiveness of Autologous Arteriovenous Fistulas Versus Hemodialysis Access Grafts in Elderly Patients","has_exemption":false,"start_date":"2016-01-28","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"E. Peden, MD","sponsor_slug":"e-peden-md","status":"overdue","is_pact":true,"days_late":53},{"registry_id":"NCT02873962","publication_url":"https://clinicaltrials.gov/study/NCT02873962","title":"A Phase II Study With a Safety lead-in of Nivolumab in Combination With Bevacizumab or in Combination With Bevacizumab and Rucaparib for the Treatment of Relapsed Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer","has_exemption":false,"start_date":"2016-11-10","completion_date":"2025-02-28","has_results":true,"results_due":true,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"reported-late","is_pact":true,"days_late":13},{"registry_id":"NCT02438306","publication_url":"https://clinicaltrials.gov/study/NCT02438306","title":"Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients With Ischemic Heart Failure (CardiAMP Heart Failure Trial)","has_exemption":false,"start_date":"2016-12-31","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"BioCardia, Inc.","sponsor_slug":"biocardia-inc","status":"overdue","is_pact":true,"days_late":53},{"registry_id":"NCT03730454","publication_url":"https://clinicaltrials.gov/study/NCT03730454","title":"A Multi-Center Randomized Trial of Transanastomotic Tube for Proximal Esophageal Atresia With Distal Tracheoesophageal Fistula Repair","has_exemption":false,"start_date":"2018-05-11","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Phoenix Children's Hospital","sponsor_slug":"phoenix-childrens-hospital","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT03903562","publication_url":"https://clinicaltrials.gov/study/NCT03903562","title":"A Phase 3 Open-Label Clinical Trial to Study the Immunogenicity and Safety of 9- Valent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine (V503) in Chinese Females 9 to 45 Years of Age","has_exemption":false,"start_date":"2019-04-27","completion_date":"2025-02-28","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04182633","publication_url":"https://clinicaltrials.gov/study/NCT04182633","title":"Microbiota Transfer Therapy for Children With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders","has_exemption":false,"start_date":"2019-11-15","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Arizona State University","sponsor_slug":"arizona-state-university","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT04069533","publication_url":"https://clinicaltrials.gov/study/NCT04069533","title":"A Phase II Clinical Trial to Evaluate the Efficacy of the Infusion of Autologous CD34+ Cells Transduced With a Lentiviral Vector Carrying the FANCA Gene (Orphan Drug) in Patients With Fanconi Anemia Subtype A","has_exemption":false,"start_date":"2019-11-28","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Rocket Pharmaceuticals Inc.","sponsor_slug":"rocket-pharmaceuticals-inc","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT04004416","publication_url":"https://clinicaltrials.gov/study/NCT04004416","title":"Multi-modal Assessment of GABA Function in Psychosis","has_exemption":false,"start_date":"2020-01-16","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04227184","publication_url":"https://clinicaltrials.gov/study/NCT04227184","title":"Investigation of Brain Mechanisms Involved in Urgency Urinary Incontinence","has_exemption":false,"start_date":"2020-02-13","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Becky Clarkson","sponsor_slug":"becky-clarkson","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03884374","publication_url":"https://clinicaltrials.gov/study/NCT03884374","title":"Pain Relief for OsteoArthritis Through Combined Treatment (PROACT)","has_exemption":false,"start_date":"2020-03-13","completion_date":"2025-02-28","has_results":true,"results_due":true,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04316013","publication_url":"https://clinicaltrials.gov/study/NCT04316013","title":"Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial","has_exemption":false,"start_date":"2020-07-31","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Peter MacCallum Cancer Centre, Australia","sponsor_slug":"peter-maccallum-cancer-centre-australia","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT04228289","publication_url":"https://clinicaltrials.gov/study/NCT04228289","title":"Enhancing Prolonged Exposure Therapy for PTSD With Oxytocin","has_exemption":false,"start_date":"2021-01-01","completion_date":"2025-02-28","has_results":true,"results_due":true,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04370509","publication_url":"https://clinicaltrials.gov/study/NCT04370509","title":"A Phase II Study of Perioperative Pembrolizumab-Based Therapy in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Prior to Cytoreductive Nephrectomy or Metastasectomy","has_exemption":false,"start_date":"2021-02-09","completion_date":"2025-02-28","has_results":true,"results_due":true,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04954001","publication_url":"https://clinicaltrials.gov/study/NCT04954001","title":"A Multi-center, Open-label, Single-arm Phase I Dose-escalation and Phase II Dose-expansion Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1","has_exemption":false,"start_date":"2021-03-26","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.","sponsor_slug":"shanghai-fosun-pharmaceutical-industrial-development-co-ltd","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05023278","publication_url":"https://clinicaltrials.gov/study/NCT05023278","title":"The Use of Venlafaxine in Reducing Acute Post-Surgical Pain and Opioid Consumption in Primary Total Knee Replacement","has_exemption":false,"start_date":"2021-05-10","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"reported-late","is_pact":false,"days_late":9},{"registry_id":"NCT04913337","publication_url":"https://clinicaltrials.gov/study/NCT04913337","title":"A Phase 1/2 Dose Escalation/Expansion Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies","has_exemption":false,"start_date":"2021-06-09","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"NGM Biopharmaceuticals, Inc","sponsor_slug":"ngm-biopharmaceuticals-inc","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT04793750","publication_url":"https://clinicaltrials.gov/study/NCT04793750","title":"Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC): Performance Evaluation of Novel POC HIV Tests in Baltimore","has_exemption":false,"start_date":"2021-08-18","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04998773","publication_url":"https://clinicaltrials.gov/study/NCT04998773","title":"Efficacy, Clinical and Neuroimaging Biomarkers of Response of Two Intensive/Spaced Protocols of Theta-Burst Transcranial Magnetic Stimulation in Resistant Depression: a Randomized Double-blinded Placebo-controlled Clinical Trial","has_exemption":false,"start_date":"2021-09-15","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Instituto de Investigacion Sanitaria La Fe","sponsor_slug":"instituto-de-investigacion-sanitaria-la-fe","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05128487","publication_url":"https://clinicaltrials.gov/study/NCT05128487","title":"A Phase 1/2, Open-label Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of NDI-101150 Administered as Monotherapy or in Combination With Pembrolizumab in Patients With Solid Tumors","has_exemption":false,"start_date":"2021-11-05","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Nimbus Saturn, Inc.","sponsor_slug":"nimbus-saturn-inc","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05184335","publication_url":"https://clinicaltrials.gov/study/NCT05184335","title":"Phase 3, Randomized, 28 Days, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Brilaroxazine (RP5063) in Subjects With Schizophrenia, Followed by a 52-Week Open-label Extension","has_exemption":false,"start_date":"2022-01-24","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Reviva Pharmaceuticals","sponsor_slug":"reviva-pharmaceuticals","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05220397","publication_url":"https://clinicaltrials.gov/study/NCT05220397","title":"A Phase III, Prospective, Open-Label, Randomized Clinical Trial Evaluating the Augmenting of Anti-SARS-CoV2 Immunity in Kidney Transplant Recipients Via a Heterologous Additional Dose With Janssen Ad26.CoV2.S Vaccine","has_exemption":false,"start_date":"2022-04-11","completion_date":"2025-02-28","has_results":true,"results_due":true,"sponsor_name":"Mark Stegall","sponsor_slug":"mark-stegall","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05243303","publication_url":"https://clinicaltrials.gov/study/NCT05243303","title":"Augmenting Standard-of-care Treatment of Plaque Psoriasis by Neuromodulation","has_exemption":false,"start_date":"2022-04-26","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Burrell College of Osteopathic Medicine","sponsor_slug":"burrell-college-of-osteopathic-medicine","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05362578","publication_url":"https://clinicaltrials.gov/study/NCT05362578","title":"Wearable Transcutaneous Electrical Acustimulation for Gastroparesis","has_exemption":false,"start_date":"2022-09-08","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05597267","publication_url":"https://clinicaltrials.gov/study/NCT05597267","title":"The MIRIA Acne Scar Study","has_exemption":false,"start_date":"2022-11-04","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"AVAVA, Inc.","sponsor_slug":"avava-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04925960","publication_url":"https://clinicaltrials.gov/study/NCT04925960","title":"A Prospective, Randomized, Double-Blind, Placebo-Controlled, Single-Center Study of Oral Epalrestat Therapy in Pediatric Subjects With Phosphomannomutase 2-congenital Disorder of Glycosylation (PMM2-CDG)","has_exemption":false,"start_date":"2022-11-10","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Maggie's Pearl, LLC","sponsor_slug":"maggies-pearl-llc","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05688280","publication_url":"https://clinicaltrials.gov/study/NCT05688280","title":"Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. A Multicenter Phase 1b/2a Trial in Colorectal Cancer, Non-small Cell Lung Cancer, and Soft Tissue Sarcoma Patients","has_exemption":false,"start_date":"2022-11-29","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Immunophotonics, Inc.","sponsor_slug":"immunophotonics-inc","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05519293","publication_url":"https://clinicaltrials.gov/study/NCT05519293","title":"A Phase I/IIa, Open-label, Dose-escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Preliminary Anti-tumor Activity of H002 in Patients With Active EGFR Mutation Locally Advanced or Metastatic NSCLC","has_exemption":false,"start_date":"2022-12-15","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"RedCloud Bio","sponsor_slug":"redcloud-bio","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05749250","publication_url":"https://clinicaltrials.gov/study/NCT05749250","title":"Ultrasound Cavitation for Treatment of Non-healing Ulcers in Critical Limb Ischemia","has_exemption":false,"start_date":"2023-01-01","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"reported-late","is_pact":false,"days_late":33},{"registry_id":"NCT06822218","publication_url":"https://clinicaltrials.gov/study/NCT06822218","title":"High Tone Power Therapy Versus Transcutanuoselectrical Nerve Stimulation on Polyneuropathic Pain in Diabetic Patients","has_exemption":false,"start_date":"2023-01-01","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Cairo University","sponsor_slug":"cairo-university","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05763329","publication_url":"https://clinicaltrials.gov/study/NCT05763329","title":"A Randomized, Double-blind, Placebo-Controlled Trial on the Effects of Lemborexant as a Treatment for Moderate-to-severe OSA Patients With Low Arousal Threshold","has_exemption":false,"start_date":"2023-02-01","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Chulalongkorn University","sponsor_slug":"chulalongkorn-university","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05868993","publication_url":"https://clinicaltrials.gov/study/NCT05868993","title":"Optimal Effective Local Anesthetic Volume for Pain Relief Using Brachial Plexus Block Utilizing Continuous Reassessment Method for Arthroscopic Rotator Cuff Shoulder Surgery","has_exemption":false,"start_date":"2023-02-17","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Benaroya Research Institute","sponsor_slug":"benaroya-research-institute","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT06419049","publication_url":"https://clinicaltrials.gov/study/NCT06419049","title":"Impact of Standing Programs in Children With Spina Bifida: A Single Subject Design","has_exemption":false,"start_date":"2023-02-23","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"University of St. Augustine for Health Sciences","sponsor_slug":"university-of-st-augustine-for-health-sciences","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05667324","publication_url":"https://clinicaltrials.gov/study/NCT05667324","title":"Post-operative Pain Control With Sphenopalantine Ganglion Nerve Block in Septorhinoplasty Patients","has_exemption":false,"start_date":"2023-04-12","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05726279","publication_url":"https://clinicaltrials.gov/study/NCT05726279","title":"PROtecting Maternal Brains From Injury and Stroke (PROMIS)","has_exemption":false,"start_date":"2023-05-04","completion_date":"2025-02-28","has_results":true,"results_due":true,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05764993","publication_url":"https://clinicaltrials.gov/study/NCT05764993","title":"Prevalence of Humoral Immune Deficiency in Patients With Frequent Exacerbations of COPD, and the Effect of Immunoglobulin Replacement on Future Exacerbations","has_exemption":false,"start_date":"2023-06-01","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Rochester General Hospital","sponsor_slug":"rochester-general-hospital","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05766748","publication_url":"https://clinicaltrials.gov/study/NCT05766748","title":"A Phase I/II Open Label Study to Assess Safety and Preliminary Evidence of a Therapeutic Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2023-06-01","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Cantex Pharmaceuticals","sponsor_slug":"cantex-pharmaceuticals","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05933265","publication_url":"https://clinicaltrials.gov/study/NCT05933265","title":"A Phase 1/2 Dose Escalation and Cohort Expansion Study of LP-184 in Patients With Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2023-06-09","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Lantern Pharma Inc.","sponsor_slug":"lantern-pharma-inc","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05767346","publication_url":"https://clinicaltrials.gov/study/NCT05767346","title":"A Phase 3, Multi-center, Randomized, Double-blind Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy","has_exemption":false,"start_date":"2023-06-20","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Cytokinetics","sponsor_slug":"cytokinetics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05936567","publication_url":"https://clinicaltrials.gov/study/NCT05936567","title":"A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy, and Safety Study of Povorcitinib in Participants With Chronic Spontaneous Urticaria","has_exemption":false,"start_date":"2023-07-31","completion_date":"2025-02-28","has_results":true,"results_due":true,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06287151","publication_url":"https://clinicaltrials.gov/study/NCT06287151","title":"Assessment of Regional Anesthetic Blockade Using Non-Invasive Surface Electromyogram (EMG)","has_exemption":false,"start_date":"2023-08-09","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT06111482","publication_url":"https://clinicaltrials.gov/study/NCT06111482","title":"Clinical Study to Evaluate Different Energy-based Devices for Aesthetic Treatments.","has_exemption":false,"start_date":"2023-09-28","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Cynosure, Inc.","sponsor_slug":"cynosure-inc","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05998395","publication_url":"https://clinicaltrials.gov/study/NCT05998395","title":"Single Patient Study of JAK/STAT Inhibition in CNS Kohlmeier-Degos Disease","has_exemption":false,"start_date":"2023-09-28","completion_date":"2025-02-28","has_results":true,"results_due":true,"sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","sponsor_slug":"national-heart-lung-and-blood-institute-nhlbi","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05608824","publication_url":"https://clinicaltrials.gov/study/NCT05608824","title":"Evaluation of Lower Extremity Athletic Injuries and Response to Treatment Using Shear Wave Elastography and Micro-vascular Flow Imaging","has_exemption":false,"start_date":"2023-10-01","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT06122649","publication_url":"https://clinicaltrials.gov/study/NCT06122649","title":"A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Apremilast 30 mg Twice Daily in Chinese Subjects With Moderate to Severe Plaque-type Psoriasis","has_exemption":true,"start_date":"2023-11-27","completion_date":"2025-02-28","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00763828","publication_url":"https://clinicaltrials.gov/study/NCT00763828","title":"Can Hypothermia be Incorporated Into Primary Angioplasty for Heart Attack?","has_exemption":false,"start_date":"2024-01-28","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Life Recovery Systems","sponsor_slug":"life-recovery-systems","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT06039202","publication_url":"https://clinicaltrials.gov/study/NCT06039202","title":"A Phase 2, Randomized, Open Label Study to Evaluate Efficacy, Safety, and Tolerability of CA102N Combined With Trifluridine/Tipiracil (TAS-102) Compared to Bevacizumab Combined With TAS-102 in Subjects With Metastatic Colorectal Cancer (mCRC) Who Failed the Standard Treatment","has_exemption":false,"start_date":"2024-01-31","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Holy Stone Healthcare Co., Ltd","sponsor_slug":"holy-stone-healthcare-co-ltd","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT06892535","publication_url":"https://clinicaltrials.gov/study/NCT06892535","title":"Low-Dose Albumin Infusion for the Prevention of Paracentesis Induced Circulatory Dysfunction (PICD), After Large Volume Paracentesis in Decompensated Cirrhosis of Liver.","has_exemption":false,"start_date":"2024-02-02","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","sponsor_slug":"bangabandhu-sheikh-mujib-medical-university-dhaka-bangladesh","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT06074185","publication_url":"https://clinicaltrials.gov/study/NCT06074185","title":"Treating Respiratory Emergencies in Children Study","has_exemption":false,"start_date":"2024-02-19","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06321796","publication_url":"https://clinicaltrials.gov/study/NCT06321796","title":"Microbiota Transfer Therapy for Children and Adults With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders: MTP-101 P","has_exemption":false,"start_date":"2024-02-27","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Gut-Brain-Axis Therapeutics Inc.","sponsor_slug":"gut-brain-axis-therapeutics-inc","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT06230484","publication_url":"https://clinicaltrials.gov/study/NCT06230484","title":"A Prospective Clinical Trial on the Outcomes of Invisalign First Palatal Expander","has_exemption":false,"start_date":"2024-02-29","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"University of British Columbia","sponsor_slug":"university-of-british-columbia","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT06764745","publication_url":"https://clinicaltrials.gov/study/NCT06764745","title":"Effect of Different Ventilation Modes on POCD in Elderly Patients with Abdominal Wall Hernia: a Randomized Controlled Trial","has_exemption":false,"start_date":"2024-03-01","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Inner Mongolia University of Science and Technology","sponsor_slug":"inner-mongolia-university-of-science-and-technology","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT05567562","publication_url":"https://clinicaltrials.gov/study/NCT05567562","title":"Dual Anti-platelet Therapy in Chronic Obstructive Pulmonary Disease Study","has_exemption":false,"start_date":"2024-03-27","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"reported-late","is_pact":false,"days_late":4},{"registry_id":"NCT06783764","publication_url":"https://clinicaltrials.gov/study/NCT06783764","title":"Comparative Study Between Combined Modified Pectoral Nerve Block (PECSΙΙ) and Transversus Thoracic Plane Block Versus Erector Spinae Plane Block for Post-operative Analgesia Following Breast Surgeries, (randomized Clinical Trial Study)","has_exemption":false,"start_date":"2024-05-01","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Ain Shams University","sponsor_slug":"ain-shams-university","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT06479161","publication_url":"https://clinicaltrials.gov/study/NCT06479161","title":"Effects of Oral Tranexamic Acid Following Total Knee Arthroplasty on Postoperative Pain and Range of Motion: A Randomized Control Trial","has_exemption":false,"start_date":"2024-06-10","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Matthew Grosso, MD","sponsor_slug":"matthew-grosso-md","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT06491173","publication_url":"https://clinicaltrials.gov/study/NCT06491173","title":"Assessment of Accuracy, Precision, and Feasibility of a Handheld Near-Infrared Light Device (InfraScanner 2500™) in Detecting Traumatic Intracranial Hemorrhage in Uganda","has_exemption":false,"start_date":"2024-07-30","completion_date":"2025-02-28","has_results":true,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06433999","publication_url":"https://clinicaltrials.gov/study/NCT06433999","title":"A 12-Week Open-Label Pilot Study to Investigate the Efficacy and Safety of Oral Brepocitinib in Adults With Skin-Predominant Dermatomyositis","has_exemption":false,"start_date":"2024-08-28","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Priovant Therapeutics, Inc.","sponsor_slug":"priovant-therapeutics-inc","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT06659055","publication_url":"https://clinicaltrials.gov/study/NCT06659055","title":"Bone Mineral Density Assessment Using Dual-energy Stereoradiography: Agreement Between BMD T-scores From EOSedge™ Versus Traditional DXA - BMD Agreement Study","has_exemption":false,"start_date":"2024-09-11","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Alphatec Spine, Inc.","sponsor_slug":"alphatec-spine-inc","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT06643767","publication_url":"https://clinicaltrials.gov/study/NCT06643767","title":"Evaluation of the Bexa Breast Examination (BBE) as an Effective Solution to Breast Cancer Early Detection","has_exemption":false,"start_date":"2024-10-16","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Sure, Inc.","sponsor_slug":"sure-inc","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT06830811","publication_url":"https://clinicaltrials.gov/study/NCT06830811","title":"Precision Assessment of Bone Mineral Density (BMD) Measurement With EOSedge™ - BMD Precision Study","has_exemption":false,"start_date":"2024-11-13","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Alphatec Spine, Inc.","sponsor_slug":"alphatec-spine-inc","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT06700460","publication_url":"https://clinicaltrials.gov/study/NCT06700460","title":"A Randomized Evaluation of Clinical Outcomes Following Bilateral Implantation of EVO+ ICL Lenses or Bilateral Wavefront-Optimized LASIK (EVOlve)","has_exemption":false,"start_date":"2024-11-27","completion_date":"2025-02-28","has_results":false,"results_due":true,"sponsor_name":"Vance Thompson Vision","sponsor_slug":"vance-thompson-vision","status":"overdue","is_pact":false,"days_late":53},{"registry_id":"NCT03486821","publication_url":"https://clinicaltrials.gov/study/NCT03486821","title":"Pilot Trial of Ultra-hypofractionated Radiation in Early Prostate Cancer","has_exemption":false,"start_date":"2018-03-22","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT03142568","publication_url":"https://clinicaltrials.gov/study/NCT03142568","title":"Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary Dysplasia","has_exemption":false,"start_date":"2018-04-02","completion_date":"2025-03-01","has_results":true,"results_due":true,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03847636","publication_url":"https://clinicaltrials.gov/study/NCT03847636","title":"Safety and Efficacy of Cryoballoon Ablation for Treatment of Sporadic and Familial Nonampullary Nonpolypoid Duodenal Adenomas (the C2D2 Trial)","has_exemption":false,"start_date":"2019-05-13","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT04098003","publication_url":"https://clinicaltrials.gov/study/NCT04098003","title":"INvestigation of the Gut microbiomE and STatin Response (INGEST)","has_exemption":true,"start_date":"2020-02-06","completion_date":"2025-03-01","has_results":false,"results_due":false,"sponsor_name":"Sony Tuteja","sponsor_slug":"sony-tuteja","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03909737","publication_url":"https://clinicaltrials.gov/study/NCT03909737","title":"Sauver Avec l'Azithromycine en Traitant Les Femmes Enceintes et Les Enfants (SANTE)","has_exemption":false,"start_date":"2020-09-24","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT03632031","publication_url":"https://clinicaltrials.gov/study/NCT03632031","title":"Treatment of Wounds Using Oasis® Extracellular Matrix in the Community Setting","has_exemption":false,"start_date":"2021-03-01","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Cook Biotech Incorporated","sponsor_slug":"cook-biotech-incorporated","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT04743934","publication_url":"https://clinicaltrials.gov/study/NCT04743934","title":"RAD 2003/XUAB2104: Randomized Phase II Trial of Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer","has_exemption":false,"start_date":"2021-07-02","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Andrew McDonald","sponsor_slug":"andrew-mcdonald","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04935697","publication_url":"https://clinicaltrials.gov/study/NCT04935697","title":"Non-invasive Vagal Neurostimulation (nVNS) to Mitigate Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress and Acute Lung Injury","has_exemption":false,"start_date":"2021-08-04","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","sponsor_slug":"allegheny-singer-research-institute-also-known-as-allegheny-health-network-research-institute","status":"reported-late","is_pact":false,"days_late":25},{"registry_id":"NCT03904498","publication_url":"https://clinicaltrials.gov/study/NCT03904498","title":"COMT Inhibition as a Potential Therapeutic Target Among Individuals With Comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder","has_exemption":false,"start_date":"2021-08-16","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT04736394","publication_url":"https://clinicaltrials.gov/study/NCT04736394","title":"A Multi-center, Randomized, Open-label, Parallel-controlled Phase 3 Clinical Trial to Evaluate the Clinical Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients","has_exemption":false,"start_date":"2021-09-29","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Jiangsu Yahong Meditech Co., Ltd aka Asieris","sponsor_slug":"jiangsu-yahong-meditech-co-ltd-aka-asieris","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT04811287","publication_url":"https://clinicaltrials.gov/study/NCT04811287","title":"Utilizing Platelet-Rich Plasma as an Adjuvant to Carpal Tunnel Release for Severe Carpal Tunnel Syndrome","has_exemption":false,"start_date":"2021-10-15","completion_date":"2025-03-01","has_results":true,"results_due":true,"sponsor_name":"Michael Fredericson, MD","sponsor_slug":"michael-fredericson-md","status":"reported-late","is_pact":false,"days_late":6},{"registry_id":"NCT05280496","publication_url":"https://clinicaltrials.gov/study/NCT05280496","title":"Implementation of a Pragmatic Approach to Lower Diabetes Mellitus Risk After a Diagnosis of Gestational Diabetes Mellitus","has_exemption":false,"start_date":"2022-06-01","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Tufts Medical Center","sponsor_slug":"tufts-medical-center","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT05415917","publication_url":"https://clinicaltrials.gov/study/NCT05415917","title":"Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy","has_exemption":false,"start_date":"2022-07-29","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT05263583","publication_url":"https://clinicaltrials.gov/study/NCT05263583","title":"A Phase 2, Multicenter, Open Label Dose-ranging Study of Sepantronium Bromide in Patients With Relapsed/Refractory c-Myc Rearranged High-grade B-cell Lymphoma (HGBCL)","has_exemption":false,"start_date":"2022-12-09","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Cothera Bioscience, Inc","sponsor_slug":"cothera-bioscience-inc","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT04932096","publication_url":"https://clinicaltrials.gov/study/NCT04932096","title":"Sleep Management And Recovery After Traumatic Brain Injury in Kids (SMARTKids): Evidence for Targeting Sleep to Improve Outcomes","has_exemption":false,"start_date":"2023-01-02","completion_date":"2025-03-01","has_results":true,"results_due":true,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05668962","publication_url":"https://clinicaltrials.gov/study/NCT05668962","title":"Restoration of Radioiodine Uptake with Selpercatinib in RET Fusion-Positive Radioiodine-Refractory Thyroid Cancer: a Phase 2 Study Performed in Collaboration with the International Thyroid Oncology Group (ITOG)","has_exemption":false,"start_date":"2023-03-01","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT05857852","publication_url":"https://clinicaltrials.gov/study/NCT05857852","title":"Low-Intensity Focused Ultrasound for Cocaine Use Disorder","has_exemption":false,"start_date":"2023-03-01","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT05696613","publication_url":"https://clinicaltrials.gov/study/NCT05696613","title":"A Phase 3 Superiority Study Comparing the Safety and Efficacy of SNP-ACTH (1-39) Gel Compared to Rituximab and FDA Approved Biosimilars in Adults With Primary Membranous Nephropathy (PMN) in a Two-Phase Adaptive Trial Design","has_exemption":false,"start_date":"2023-03-13","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Cerium Pharmaceuticals, Inc.","sponsor_slug":"cerium-pharmaceuticals-inc","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT05673512","publication_url":"https://clinicaltrials.gov/study/NCT05673512","title":"To Evaluate IAH0968 in Combination With CAPEOX in a Phase II/III Clinical Study of HER2-positive Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2023-05-12","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"SUNHO（China）BioPharmaceutical CO., Ltd.","sponsor_slug":"sunhochinabiopharmaceutical-co-ltd","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT05861427","publication_url":"https://clinicaltrials.gov/study/NCT05861427","title":"A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study With An Active Treatment Extension to Evaluate the Efficacy, Safety, and Tolerability of Oral Atogepant for the Prevention of Migraine in Japanese Subjects With Episodic Migraine","has_exemption":false,"start_date":"2023-07-12","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05985408","publication_url":"https://clinicaltrials.gov/study/NCT05985408","title":"Left Ventricular Septal Pacing Based Rescue CRT Versus Right Ventricular Apical Pacing Based CRT for Chronic Heart Failure: a Randomized Controlled Trial","has_exemption":false,"start_date":"2023-09-01","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Fu Wai Hospital, Beijing, China","sponsor_slug":"fu-wai-hospital-beijing-china","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT07455474","publication_url":"https://clinicaltrials.gov/study/NCT07455474","title":"Clinical Research Study of the Benefits of Cold Compression to Reduce Opioid Use by Patients Having Undergone Arthroscopic Rotator Cuff Repair Shoulder Surgery","has_exemption":false,"start_date":"2023-10-01","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"University of Nevada, Reno","sponsor_slug":"university-of-nevada-reno","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT05158166","publication_url":"https://clinicaltrials.gov/study/NCT05158166","title":"DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia","has_exemption":false,"start_date":"2023-10-13","completion_date":"2025-03-01","has_results":true,"results_due":true,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"reported-late","is_pact":false,"days_late":3},{"registry_id":"NCT06234878","publication_url":"https://clinicaltrials.gov/study/NCT06234878","title":"Validation of REEV SENSE Biomarkers Precision for Gait Analysis in Subjects With Post-stroke Gait Impairment","has_exemption":false,"start_date":"2024-01-08","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"REEV LLC","sponsor_slug":"reev-llc","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT06262854","publication_url":"https://clinicaltrials.gov/study/NCT06262854","title":"Efficacy and Safety of aBIo- Absorbable Antibiotic Delivery in Calcium Sulphate Granules (Stimulan®) for the Treatment of Osteomyelitis in Patients With Diabetic FOOT: a Randomised, Double Blind, Controlled Clinical Study. The BIG D-FOOT Study","has_exemption":false,"start_date":"2024-03-01","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Azienda Ospedaliero-Universitaria Careggi","sponsor_slug":"azienda-ospedaliero-universitaria-careggi","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT06266546","publication_url":"https://clinicaltrials.gov/study/NCT06266546","title":"Prophylactic Endobronchial Tranexamic Acid to Reduce Bleeding in Transbronchial Cryobiopsy","has_exemption":false,"start_date":"2024-03-01","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Youssef Yammine","sponsor_slug":"youssef-yammine","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT06274580","publication_url":"https://clinicaltrials.gov/study/NCT06274580","title":"Endovascular vs Conservative Treatment in Patients With Chronic Subdural Hematomas and Mild Symptoms: a Multicentre Randomized Trial","has_exemption":false,"start_date":"2024-03-01","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Ospedale Policlinico San Martino","sponsor_slug":"ospedale-policlinico-san-martino","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT06248476","publication_url":"https://clinicaltrials.gov/study/NCT06248476","title":"Effect of Intermittent Theta Burst Stimulation and Repetitive Transcranial Magnetic Stimulation Combined With Robotic Rehabilitation on Ambulation and Lower Extremity Motor Function in Chronic Spinal Cord Injury Patients","has_exemption":false,"start_date":"2024-03-01","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Gaziler Physical Medicine and Rehabilitation Education and Research Hospital","sponsor_slug":"gaziler-physical-medicine-and-rehabilitation-education-and-research-hospital","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT06271746","publication_url":"https://clinicaltrials.gov/study/NCT06271746","title":"A Prospective, Randomized, Double-blind, Sham-controlled Clinical Study Assessing the Safety and Efficacy of FibroNova for the Treatment of Fibromyalgia.","has_exemption":false,"start_date":"2024-03-04","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Theranica","sponsor_slug":"theranica","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT06773923","publication_url":"https://clinicaltrials.gov/study/NCT06773923","title":"Effectiveness of Patient-specific 3D-printed Resorbable Scaffolds of Polycaprolactone, Beta-tricalcium Phosphate, and Metformin Used for Maxillary Bone Regeneration: Randomized Clinical Trial","has_exemption":false,"start_date":"2024-07-01","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Universidad Austral de Chile","sponsor_slug":"universidad-austral-de-chile","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT06792864","publication_url":"https://clinicaltrials.gov/study/NCT06792864","title":"Effectiveness of 3D Printed Polycaprolactone and Tricalcium Phosphate Bone Scaffold for Bone Regeneration in Cranioplasty: Randomized Clinical Trial","has_exemption":false,"start_date":"2024-07-01","completion_date":"2025-03-01","has_results":false,"results_due":true,"sponsor_name":"Universidad Austral de Chile","sponsor_slug":"universidad-austral-de-chile","status":"overdue","is_pact":false,"days_late":52},{"registry_id":"NCT06315699","publication_url":"https://clinicaltrials.gov/study/NCT06315699","title":"Randomized, Double-blind, Controlled Study of Clomastine Fumarate in the Treatment of Williams Syndrome","has_exemption":false,"start_date":"2024-03-20","completion_date":"2025-03-02","has_results":false,"results_due":true,"sponsor_name":"Qilu Hospital of Shandong University","sponsor_slug":"qilu-hospital-of-shandong-university","status":"overdue","is_pact":false,"days_late":51},{"registry_id":"NCT03587740","publication_url":"https://clinicaltrials.gov/study/NCT03587740","title":"ATOP TRIAL: Adjuvant Ado-Trastuzumab Emtansine (T-DM1) for Older Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer","has_exemption":false,"start_date":"2018-08-22","completion_date":"2025-03-03","has_results":false,"results_due":true,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03710122","publication_url":"https://clinicaltrials.gov/study/NCT03710122","title":"A Prospective, Randomized, Multi-centered, Placebo-controlled Clinical Trial of Oral Vanycomycin in Adults With Primary Sclerosing Cholangitis","has_exemption":false,"start_date":"2020-01-23","completion_date":"2025-03-03","has_results":false,"results_due":true,"sponsor_name":"Elizabeth Carey","sponsor_slug":"elizabeth-carey","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04675294","publication_url":"https://clinicaltrials.gov/study/NCT04675294","title":"A Phase 2 Study of ALX148 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)","has_exemption":false,"start_date":"2021-04-02","completion_date":"2025-03-03","has_results":false,"results_due":true,"sponsor_name":"ALX Oncology Inc.","sponsor_slug":"alx-oncology-inc","status":"overdue","is_pact":false,"days_late":50},{"registry_id":"NCT04117074","publication_url":"https://clinicaltrials.gov/study/NCT04117074","title":"A Non-Inferiority Randomized Trial Comparing the Impact of Thoracic Epidural Analgesia Versus Surgical Site Infiltration With Liposomal Bupivicaine on the Postoperative Recovery of Patients Following Open Gynecologic Surgery","has_exemption":false,"start_date":"2021-04-14","completion_date":"2025-03-03","has_results":false,"results_due":true,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"reported-late","is_pact":false,"days_late":27},{"registry_id":"NCT04675333","publication_url":"https://clinicaltrials.gov/study/NCT04675333","title":"A Phase 2 Study of ALX148 in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)","has_exemption":false,"start_date":"2021-05-10","completion_date":"2025-03-03","has_results":false,"results_due":true,"sponsor_name":"ALX Oncology Inc.","sponsor_slug":"alx-oncology-inc","status":"overdue","is_pact":false,"days_late":50},{"registry_id":"NCT05041426","publication_url":"https://clinicaltrials.gov/study/NCT05041426","title":"An Open-label Pilot Protocol to Evaluate the Efficacy of Letermovir for the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Lung Transplant Recipients With Idiopathic Pulmonary Fibrosis","has_exemption":false,"start_date":"2021-12-06","completion_date":"2025-03-03","has_results":true,"results_due":true,"sponsor_name":"Fernanda P Silveira, MD, MS","sponsor_slug":"fernanda-p-silveira-md-ms","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05280470","publication_url":"https://clinicaltrials.gov/study/NCT05280470","title":"A Phase 2, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody Drug Conjugate (ADC), in Subjects With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) (IDeate-Lung01)","has_exemption":true,"start_date":"2022-03-09","completion_date":"2025-03-03","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05662306","publication_url":"https://clinicaltrials.gov/study/NCT05662306","title":"Comprehensive Treatment of Early Course Schizophrenia: A Nonrandomized Study of Long Acting Injectable Antipsychotic Medication Combined With Cognitive and Functional Skills Training","has_exemption":false,"start_date":"2024-01-23","completion_date":"2025-03-03","has_results":true,"results_due":true,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06192927","publication_url":"https://clinicaltrials.gov/study/NCT06192927","title":"A Phase 2, Multi-Centre, Randomised, Double-Blind, Sham Controlled Proof of Concept Trial Evaluating the Efficacy and Safety of TenoMiR by Injection in Subjects With Lateral Epicondylitis","has_exemption":false,"start_date":"2024-04-10","completion_date":"2025-03-03","has_results":false,"results_due":true,"sponsor_name":"Causeway Therapeutics","sponsor_slug":"causeway-therapeutics","status":"overdue","is_pact":false,"days_late":50},{"registry_id":"NCT06178055","publication_url":"https://clinicaltrials.gov/study/NCT06178055","title":"A Phase 2, Double-masked, Randomized, Sham-controlled, Multiple-dose Study of the Efficacy and Safety of Intravitreal KUS121 in the Treatment of Non-Arteritic Central Retinal Artery Occlusion (CRAO)","has_exemption":false,"start_date":"2024-04-16","completion_date":"2025-03-03","has_results":false,"results_due":true,"sponsor_name":"Kyoto Drug Discovery and Development Co., Ltd.","sponsor_slug":"kyoto-drug-discovery-and-development-co-ltd","status":"overdue","is_pact":false,"days_late":50},{"registry_id":"NCT02264678","publication_url":"https://clinicaltrials.gov/study/NCT02264678","title":"A Modular Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ceralasertib in Combination With Cytotoxic Chemotherapy and/or DNA Damage Repair/Novel Anti-cancer Agents in Patients With Advanced Solid Malignancies.","has_exemption":false,"start_date":"2014-10-31","completion_date":"2025-03-04","has_results":false,"results_due":true,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"overdue","is_pact":true,"days_late":49},{"registry_id":"NCT02964182","publication_url":"https://clinicaltrials.gov/study/NCT02964182","title":"Evaluating Concomitant Use of Very Low Nicotine Content Cigarettes and E-Cigarettes Among Daily and Non-Daily Smokers","has_exemption":false,"start_date":"2017-10-26","completion_date":"2025-03-04","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04801849","publication_url":"https://clinicaltrials.gov/study/NCT04801849","title":"Vitamin E Dosing Study (VEDS): A Dose Finding Study of Vitamin E for the Treatment of Adult NAFLD","has_exemption":false,"start_date":"2022-08-05","completion_date":"2025-03-04","has_results":true,"results_due":true,"sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","sponsor_slug":"national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05893537","publication_url":"https://clinicaltrials.gov/study/NCT05893537","title":"A Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).","has_exemption":false,"start_date":"2023-06-16","completion_date":"2025-03-04","has_results":false,"results_due":true,"sponsor_name":"Cognition Therapeutics","sponsor_slug":"cognition-therapeutics","status":"reported-late","is_pact":false,"days_late":36},{"registry_id":"NCT06246513","publication_url":"https://clinicaltrials.gov/study/NCT06246513","title":"A Phase 3 Multinational, Open-label, Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9003 in Subjects With Limb Girdle Muscular Dystrophy 2E/R4","has_exemption":true,"start_date":"2024-01-15","completion_date":"2025-03-04","has_results":false,"results_due":false,"sponsor_name":"Sarepta Therapeutics, Inc.","sponsor_slug":"sarepta-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06445075","publication_url":"https://clinicaltrials.gov/study/NCT06445075","title":"A Phase 2 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Apitegromab in Overweight and Obese Adult Subjects","has_exemption":true,"start_date":"2024-05-21","completion_date":"2025-03-04","has_results":false,"results_due":false,"sponsor_name":"Scholar Rock, Inc.","sponsor_slug":"scholar-rock-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04548609","publication_url":"https://clinicaltrials.gov/study/NCT04548609","title":"Transcranial Direct Current Stimulation (tDCS) Modulation of Neurocognitive Processes Underlying Pediatric Obsessive Compulsive Disorder (OCD)","has_exemption":false,"start_date":"2021-01-25","completion_date":"2025-03-05","has_results":false,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04832854","publication_url":"https://clinicaltrials.gov/study/NCT04832854","title":"A Phase II, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Patients With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2021-04-23","completion_date":"2025-03-05","has_results":true,"results_due":true,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04747145","publication_url":"https://clinicaltrials.gov/study/NCT04747145","title":"A Phase II Study Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma (PRORADGLIO Study)","has_exemption":false,"start_date":"2021-06-03","completion_date":"2025-03-05","has_results":false,"results_due":true,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"overdue","is_pact":false,"days_late":48},{"registry_id":"NCT05116189","publication_url":"https://clinicaltrials.gov/study/NCT05116189","title":"A Phase 3, Randomized, Double-Blind Study of Pembrolizumab Versus Placebo in Combination With Paclitaxel With or Without Bevacizumab for the Treatment of Platinum-resistant Recurrent Ovarian Cancer (KEYNOTE-B96/ENGOT-ov65)","has_exemption":false,"start_date":"2021-12-13","completion_date":"2025-03-05","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05326412","publication_url":"https://clinicaltrials.gov/study/NCT05326412","title":"A Phase 2a, Open-label, Two-part Study to Evaluate the Mechanism of Action of Itepekimab (Anti-IL-33 mAb) on Airway Inflammation in Patients With Chronic Obstructive Pulmonary Disease (COPD)","has_exemption":true,"start_date":"2022-05-19","completion_date":"2025-03-05","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05514535","publication_url":"https://clinicaltrials.gov/study/NCT05514535","title":"Efficacy and Safety of Once-weekly Semaglutide S.C. 2.0 mg as Add-on to Dose-reduced Insulin Glargine vs Titrated Insulin Glargine in Participants With Type 2 Diabetes and Overweight","has_exemption":false,"start_date":"2022-08-29","completion_date":"2025-03-05","has_results":false,"results_due":true,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05492500","publication_url":"https://clinicaltrials.gov/study/NCT05492500","title":"A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 4-ARM STUDY TO INVESTIGATE SYMPTOMS, FUNCTION, HEALTH-RELATED QUALITY OF LIFE AND SAFETY WITH REPEATED SUBCUTANEOUS ADMINISTRATION OF PONSEGROMAB VERSUS PLACEBO IN ADULT PARTICIPANTS WITH HEART FAILURE","has_exemption":false,"start_date":"2022-09-26","completion_date":"2025-03-05","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05570305","publication_url":"https://clinicaltrials.gov/study/NCT05570305","title":"A Study to Assess the Effects of the Endothelin Receptor Antagonist Zibotentan and the SGLT2 Inhibitor Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria: a Randomized Double Blind Cross-Over Trial","has_exemption":false,"start_date":"2022-10-06","completion_date":"2025-03-05","has_results":false,"results_due":true,"sponsor_name":"University Medical Center Groningen","sponsor_slug":"university-medical-center-groningen","status":"overdue","is_pact":false,"days_late":48},{"registry_id":"NCT05975905","publication_url":"https://clinicaltrials.gov/study/NCT05975905","title":"A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (TROPOS Study)","has_exemption":false,"start_date":"2023-10-17","completion_date":"2025-03-05","has_results":false,"results_due":true,"sponsor_name":"Keros Therapeutics, Inc.","sponsor_slug":"keros-therapeutics-inc","status":"reported-late","is_pact":false,"days_late":6},{"registry_id":"NCT06310070","publication_url":"https://clinicaltrials.gov/study/NCT06310070","title":"3D Printed Personalized Ostomy Appliance","has_exemption":false,"start_date":"2024-05-10","completion_date":"2025-03-05","has_results":false,"results_due":true,"sponsor_name":"Carilion Clinic","sponsor_slug":"carilion-clinic","status":"overdue","is_pact":false,"days_late":48},{"registry_id":"NCT06609018","publication_url":"https://clinicaltrials.gov/study/NCT06609018","title":"Clinical Investigation of Buttermere (LENS 271) Soft Contact Lenses","has_exemption":true,"start_date":"2024-08-01","completion_date":"2025-03-05","has_results":false,"results_due":false,"sponsor_name":"Coopervision, Inc.","sponsor_slug":"coopervision-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06544772","publication_url":"https://clinicaltrials.gov/study/NCT06544772","title":"Pilot Study of a Smartphone-Based Program in Adults to Measure Switch Rates From Cigarettes to Smoke-free Nicotine Products (C-520)","has_exemption":false,"start_date":"2024-08-16","completion_date":"2025-03-05","has_results":false,"results_due":true,"sponsor_name":"Pivot Health Technologies Inc.","sponsor_slug":"pivot-health-technologies-inc","status":"overdue","is_pact":false,"days_late":48},{"registry_id":"NCT03476330","publication_url":"https://clinicaltrials.gov/study/NCT03476330","title":"Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia","has_exemption":false,"start_date":"2018-05-08","completion_date":"2025-03-06","has_results":true,"results_due":true,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04677114","publication_url":"https://clinicaltrials.gov/study/NCT04677114","title":"Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections","has_exemption":false,"start_date":"2021-03-16","completion_date":"2025-03-06","has_results":true,"results_due":true,"sponsor_name":"Laura Fanucchi","sponsor_slug":"laura-fanucchi","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04743310","publication_url":"https://clinicaltrials.gov/study/NCT04743310","title":"A Phase 2 Study of Fluorescence Detection of Adult Primary Central Nervous System Tumors in Subjects Receiving Tozuleristide and Imaged With the Canvas System","has_exemption":false,"start_date":"2021-09-30","completion_date":"2025-03-06","has_results":false,"results_due":true,"sponsor_name":"John Yu","sponsor_slug":"john-yu","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05109442","publication_url":"https://clinicaltrials.gov/study/NCT05109442","title":"A Phase 1/2a Open Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of AFM24 in Combination With Atezolizumab in Patients With Selected Advanced/Metastatic EGFR-expressing Cancers","has_exemption":false,"start_date":"2021-11-19","completion_date":"2025-03-06","has_results":true,"results_due":true,"sponsor_name":"Affimed GmbH","sponsor_slug":"affimed-gmbh","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05120947","publication_url":"https://clinicaltrials.gov/study/NCT05120947","title":"A Phase I Study of Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers (HART-HN)","has_exemption":false,"start_date":"2021-12-01","completion_date":"2025-03-06","has_results":true,"results_due":true,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05251753","publication_url":"https://clinicaltrials.gov/study/NCT05251753","title":"Evaluation of a Novel Sutureless Drain Securement Device (K-Lock Device) and Comparison to Standard Suture-based Drain Securement Techniques","has_exemption":false,"start_date":"2022-03-07","completion_date":"2025-03-06","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05248204","publication_url":"https://clinicaltrials.gov/study/NCT05248204","title":"Prospective, Randomized, Split-mouth Study Evaluating Clinical Performance of 3M™ Scotchbond™ Universal Plus Adhesive Compared to 3M Scotchbond Universal Adhesive for Posterior Class I & II Restorations With 3M Filtek™ Universal Restorative","has_exemption":false,"start_date":"2022-06-14","completion_date":"2025-03-06","has_results":true,"results_due":true,"sponsor_name":"Solventum US LLC","sponsor_slug":"solventum-us-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05582395","publication_url":"https://clinicaltrials.gov/study/NCT05582395","title":"A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy","has_exemption":false,"start_date":"2022-12-14","completion_date":"2025-03-06","has_results":false,"results_due":true,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05747430","publication_url":"https://clinicaltrials.gov/study/NCT05747430","title":"Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Injection Pain and Corneal Epitheliopathy","has_exemption":false,"start_date":"2023-02-22","completion_date":"2025-03-06","has_results":false,"results_due":true,"sponsor_name":"iRenix Medical, Inc.","sponsor_slug":"irenix-medical-inc","status":"overdue","is_pact":false,"days_late":47},{"registry_id":"NCT05750823","publication_url":"https://clinicaltrials.gov/study/NCT05750823","title":"An Open-Label, Phase 2, Safety, and Efficacy Study of Ruxolitinib Cream in Participants With Genital Vitiligo","has_exemption":false,"start_date":"2023-04-11","completion_date":"2025-03-06","has_results":true,"results_due":true,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05678959","publication_url":"https://clinicaltrials.gov/study/NCT05678959","title":"A Three-year, Multi-center, Double-blind, Extension Study to Evaluate the Long-term Safety and Efficacy of Ligelizumab in Patients Who Completed Ligelizumab's Phase III Studies in Food Allergy","has_exemption":false,"start_date":"2023-04-27","completion_date":"2025-03-06","has_results":true,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06362759","publication_url":"https://clinicaltrials.gov/study/NCT06362759","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Quarterly and Monthly TOUR006 in Participants With Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein","has_exemption":true,"start_date":"2024-05-15","completion_date":"2025-03-06","has_results":false,"results_due":false,"sponsor_name":"Tourmaline Bio, Inc.","sponsor_slug":"tourmaline-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03693105","publication_url":"https://clinicaltrials.gov/study/NCT03693105","title":"A Multi-Site, Randomized, Double-Blind Trial Assessing The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition","has_exemption":false,"start_date":"2024-06-30","completion_date":"2025-03-06","has_results":false,"results_due":true,"sponsor_name":"Magnus Medical","sponsor_slug":"magnus-medical","status":"overdue","is_pact":false,"days_late":47},{"registry_id":"NCT06462820","publication_url":"https://clinicaltrials.gov/study/NCT06462820","title":"SAINT® Neuromodulation System for the Treatment of Depression in an Inpatient Setting","has_exemption":false,"start_date":"2024-06-30","completion_date":"2025-03-06","has_results":false,"results_due":true,"sponsor_name":"Magnus Medical","sponsor_slug":"magnus-medical","status":"overdue","is_pact":false,"days_late":47},{"registry_id":"NCT06531395","publication_url":"https://clinicaltrials.gov/study/NCT06531395","title":"A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease","has_exemption":false,"start_date":"2024-07-17","completion_date":"2025-03-06","has_results":false,"results_due":true,"sponsor_name":"Kiniksa Pharmaceuticals International, plc","sponsor_slug":"kiniksa-pharmaceuticals-international-plc","status":"overdue","is_pact":false,"days_late":47},{"registry_id":"NCT06540807","publication_url":"https://clinicaltrials.gov/study/NCT06540807","title":"SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study: A Study to Investigate the Performance and Safety of the Colovac 2 Colorectal Anastomosis Protection Device","has_exemption":false,"start_date":"2024-07-31","completion_date":"2025-03-06","has_results":false,"results_due":true,"sponsor_name":"SafeHeal Inc","sponsor_slug":"safeheal-inc","status":"overdue","is_pact":false,"days_late":47},{"registry_id":"NCT04535193","publication_url":"https://clinicaltrials.gov/study/NCT04535193","title":"An Open-Label, Exploratory, Phase 1/2 Scintigraphy Study Evaluating 18F-mFBG for Imaging Myocardial Sympathetic Innervation in Subjects Without and With Heart Disease","has_exemption":false,"start_date":"2021-11-05","completion_date":"2025-03-07","has_results":false,"results_due":true,"sponsor_name":"Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)","sponsor_slug":"innervate-radiopharmaceuticals-llc-formerly-illumina-radiopharmaceuticals-llc","status":"overdue","is_pact":false,"days_late":46},{"registry_id":"NCT05079035","publication_url":"https://clinicaltrials.gov/study/NCT05079035","title":"A Phase 2, 52-Week Trial of TTAX03 vs. Saline as a Single Intra-articular Injection in Kellgren-Lawrence Grade 3-4 Knee OA","has_exemption":false,"start_date":"2021-12-06","completion_date":"2025-03-07","has_results":false,"results_due":true,"sponsor_name":"BioTissue Holdings, Inc","sponsor_slug":"biotissue-holdings-inc","status":"overdue","is_pact":false,"days_late":46},{"registry_id":"NCT05212610","publication_url":"https://clinicaltrials.gov/study/NCT05212610","title":"Assessing Safety of COVID-19 mRNA Vaccine Administration in the Setting of a Previous Adverse Reaction","has_exemption":false,"start_date":"2022-03-21","completion_date":"2025-03-07","has_results":true,"results_due":true,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05262855","publication_url":"https://clinicaltrials.gov/study/NCT05262855","title":"A Phase 2, Multicenter, Single Arm, Open Label Non-Randomized Study of [68Ga]FAPI-46 PET in Patients With Resectable or Borderline Resectable Pancreatic Ductal Carcinoma","has_exemption":false,"start_date":"2022-05-02","completion_date":"2025-03-07","has_results":false,"results_due":true,"sponsor_name":"SOFIE","sponsor_slug":"sofie","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05337696","publication_url":"https://clinicaltrials.gov/study/NCT05337696","title":"Circumferential Vertebral Reconstruction of Osteoporotic Compression Fractures Using a Novel Bipedicular Peek Implant","has_exemption":false,"start_date":"2022-05-10","completion_date":"2025-03-07","has_results":false,"results_due":true,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"overdue","is_pact":false,"days_late":46},{"registry_id":"NCT05498220","publication_url":"https://clinicaltrials.gov/study/NCT05498220","title":"A Phase II Trial Evaluating the Efficacy of Polatuzumab Vedotin With Rituximab, Gemcitabine, Dexamethasone, and Cisplatin (PV-RGDP) Chemotherapy for Relapsed or Refractory Diffuse Large B-cell Lymphoma","has_exemption":false,"start_date":"2023-02-17","completion_date":"2025-03-07","has_results":true,"results_due":true,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05554068","publication_url":"https://clinicaltrials.gov/study/NCT05554068","title":"Phase II, Non-randomized, Open-label Study to Assess the Immunogenicity and Clinical Efficacy of the Recombinant Zoster Vaccine for Recipients of an Allogeneic Hematopoietic Stem Cell Transplant","has_exemption":false,"start_date":"2023-03-07","completion_date":"2025-03-07","has_results":false,"results_due":true,"sponsor_name":"Loyola University","sponsor_slug":"loyola-university","status":"overdue","is_pact":false,"days_late":46},{"registry_id":"NCT05794555","publication_url":"https://clinicaltrials.gov/study/NCT05794555","title":"LiveSMART: A Sequential, Multiple Assignment Randomized Trial to Prevent Falls in Patients With Cirrhosis","has_exemption":false,"start_date":"2023-06-13","completion_date":"2025-03-07","has_results":false,"results_due":true,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06283459","publication_url":"https://clinicaltrials.gov/study/NCT06283459","title":"Phase 1/2, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a DNA Vaccine, IMNN-101, Administered as a Single Dose in Healthy Adults Previously Vaccinated Against SARS-CoV-2","has_exemption":false,"start_date":"2024-06-04","completion_date":"2025-03-07","has_results":false,"results_due":true,"sponsor_name":"Imunon","sponsor_slug":"imunon","status":"overdue","is_pact":false,"days_late":46},{"registry_id":"NCT03720171","publication_url":"https://clinicaltrials.gov/study/NCT03720171","title":"An Osseointegrated Transfemoral Prosthesis Study Evaluating Stable Neural Signal Transmission in Patients With Transfemoral Amputations","has_exemption":false,"start_date":"2018-01-17","completion_date":"2025-03-08","has_results":false,"results_due":true,"sponsor_name":"Integrum","sponsor_slug":"integrum","status":"overdue","is_pact":false,"days_late":45},{"registry_id":"NCT03978988","publication_url":"https://clinicaltrials.gov/study/NCT03978988","title":"Intracranial Thrombectomy and Extracranial Carotid Stenting Versus Intracranial Thrombectomy Alone In Acute Anterior Circulation Strokes With TANdem Occlusion : the Randomized Controlled TITAN Trial","has_exemption":false,"start_date":"2020-04-29","completion_date":"2025-03-08","has_results":false,"results_due":true,"sponsor_name":"Central Hospital, Nancy, France","sponsor_slug":"central-hospital-nancy-france","status":"overdue","is_pact":false,"days_late":45},{"registry_id":"NCT05714501","publication_url":"https://clinicaltrials.gov/study/NCT05714501","title":"Millipede AspiRation for Revascularization in Stroke (MARRS) Study","has_exemption":true,"start_date":"2023-10-09","completion_date":"2025-03-08","has_results":false,"results_due":false,"sponsor_name":"Perfuze","sponsor_slug":"perfuze","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06363461","publication_url":"https://clinicaltrials.gov/study/NCT06363461","title":"A Randomized, Vehicle-Controlled, Parallel Group Study of Topical TDM-180935 to Evaluate the Preliminary Efficacy, Safety, Tolerability, and Pharmacokinetics in Atopic Dermatitis Patients","has_exemption":true,"start_date":"2024-04-13","completion_date":"2025-03-08","has_results":false,"results_due":false,"sponsor_name":"Technoderma Medicines Inc.","sponsor_slug":"technoderma-medicines-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05542277","publication_url":"https://clinicaltrials.gov/study/NCT05542277","title":"A Pre-market, Multi-center, International, Double-blind, Randomized, Two-arms, Controlled, Prospective Clinical Investigation Assessing the Safety and Performance of a Medical Device (ClearPlasma™) for the Treatment of Patients Undergoing Coronary Artery Bypass or Valve Replacement","has_exemption":false,"start_date":"2022-11-08","completion_date":"2025-03-09","has_results":false,"results_due":true,"sponsor_name":"PlasFree Ltd.","sponsor_slug":"plasfree-ltd","status":"overdue","is_pact":false,"days_late":44},{"registry_id":"NCT06774469","publication_url":"https://clinicaltrials.gov/study/NCT06774469","title":"Effect of Overdose Ultrasound on the Articular Cartilage of the Osteoarthritic Knee in Adult Albino Rat: a Histological Study","has_exemption":false,"start_date":"2024-02-07","completion_date":"2025-03-09","has_results":false,"results_due":true,"sponsor_name":"Cairo University","sponsor_slug":"cairo-university","status":"overdue","is_pact":false,"days_late":44},{"registry_id":"NCT02482376","publication_url":"https://clinicaltrials.gov/study/NCT02482376","title":"A Phase II Preoperative Single-Fraction Partial Breast Radiotherapy in Early Stage Breast Cancer: Analysis of Pathologic Response","has_exemption":false,"start_date":"2015-10-21","completion_date":"2025-03-10","has_results":true,"results_due":true,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02706353","publication_url":"https://clinicaltrials.gov/study/NCT02706353","title":"Phase I/II Dose Escalation and Cohort Expansion of Safety and Tolerability Study of Intratumoral CD40 Agonistic Monoclonal Antibody APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma","has_exemption":false,"start_date":"2017-06-02","completion_date":"2025-03-10","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03371719","publication_url":"https://clinicaltrials.gov/study/NCT03371719","title":"A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)","has_exemption":false,"start_date":"2018-06-20","completion_date":"2025-03-10","has_results":false,"results_due":true,"sponsor_name":"NRG Oncology","sponsor_slug":"nrg-oncology","status":"reported-late","is_pact":false,"days_late":28},{"registry_id":"NCT04309396","publication_url":"https://clinicaltrials.gov/study/NCT04309396","title":"Clinical Utility of Handheld Hydrogen Breathalyzer in Identification of Non-immune Mediated Food Sensitivities (AIRE Study)","has_exemption":false,"start_date":"2020-10-01","completion_date":"2025-03-10","has_results":true,"results_due":true,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05509400","publication_url":"https://clinicaltrials.gov/study/NCT05509400","title":"BHV3000-406 (C4951004): A Phase 4, Randomized, Double-blind Placebo-Controlled, Efficacy and Tolerability Trial of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use","has_exemption":false,"start_date":"2022-10-18","completion_date":"2025-03-10","has_results":true,"results_due":true,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05813275","publication_url":"https://clinicaltrials.gov/study/NCT05813275","title":"Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of Aroxybutynin/Atomoxetine (AD109) to Placebo in Obstructive Sleep Apnea (SynAIRgy Study)","has_exemption":false,"start_date":"2023-09-16","completion_date":"2025-03-10","has_results":false,"results_due":true,"sponsor_name":"Apnimed","sponsor_slug":"apnimed","status":"overdue","is_pact":false,"days_late":43},{"registry_id":"NCT05918055","publication_url":"https://clinicaltrials.gov/study/NCT05918055","title":"A Phase I/II Trial of Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes","has_exemption":false,"start_date":"2023-11-14","completion_date":"2025-03-10","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06597344","publication_url":"https://clinicaltrials.gov/study/NCT06597344","title":"A Phase 3b, Open-label, Single-arm Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)","has_exemption":false,"start_date":"2024-10-02","completion_date":"2025-03-10","has_results":true,"results_due":true,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06641128","publication_url":"https://clinicaltrials.gov/study/NCT06641128","title":"Clinical Study Evaluating the Possible Efficacy and Protective Effect of Empagliflozin in Rheumatoid Arthritis Patients Treated with Methotrexate","has_exemption":false,"start_date":"2024-10-15","completion_date":"2025-03-10","has_results":false,"results_due":true,"sponsor_name":"Tanta University","sponsor_slug":"tanta-university","status":"overdue","is_pact":false,"days_late":43},{"registry_id":"NCT06936332","publication_url":"https://clinicaltrials.gov/study/NCT06936332","title":"A 7-week, Open Label, Single Arm Study Evaluating the Efficacy and Safety of Omnilux Clear® on Mitigating Mild to Moderate Acne in Healthy Male and Female Teenagers and Adults","has_exemption":false,"start_date":"2024-11-18","completion_date":"2025-03-10","has_results":false,"results_due":true,"sponsor_name":"Ablon Skin Institute Research Center","sponsor_slug":"ablon-skin-institute-research-center","status":"overdue","is_pact":false,"days_late":43},{"registry_id":"NCT06724952","publication_url":"https://clinicaltrials.gov/study/NCT06724952","title":"Clinical Study Evaluating Anti Rheumatic Activity and The Role of Silymarin in Attenuating Methotrexate Toxicity in Patients With Rheumatoid Arthritis","has_exemption":false,"start_date":"2024-12-10","completion_date":"2025-03-10","has_results":false,"results_due":true,"sponsor_name":"Tanta University","sponsor_slug":"tanta-university","status":"overdue","is_pact":false,"days_late":43},{"registry_id":"NCT04007393","publication_url":"https://clinicaltrials.gov/study/NCT04007393","title":"SMART Use of Medication for the Treatment of Adolescent Severe Obesity","has_exemption":false,"start_date":"2019-11-21","completion_date":"2025-03-11","has_results":false,"results_due":true,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"reported-late","is_pact":false,"days_late":2},{"registry_id":"NCT04171219","publication_url":"https://clinicaltrials.gov/study/NCT04171219","title":"A Phase 2 Basket Study of BXCL701, a Small Molecule Inhibitor of Dipeptidyl Peptidases (DPP), Administered in Combination With Pembrolizumab in Patients With Advanced Solid Cancers","has_exemption":false,"start_date":"2020-03-19","completion_date":"2025-03-11","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04365868","publication_url":"https://clinicaltrials.gov/study/NCT04365868","title":"A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis","has_exemption":false,"start_date":"2020-06-25","completion_date":"2025-03-11","has_results":false,"results_due":true,"sponsor_name":"Galectin Therapeutics Inc.","sponsor_slug":"galectin-therapeutics-inc","status":"overdue","is_pact":false,"days_late":42},{"registry_id":"NCT04240002","publication_url":"https://clinicaltrials.gov/study/NCT04240002","title":"A Phase 1/2, Multicenter, Open-Label, Single Arm, Dose Escalation and Expansion Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)","has_exemption":false,"start_date":"2020-09-04","completion_date":"2025-03-11","has_results":true,"results_due":true,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04683042","publication_url":"https://clinicaltrials.gov/study/NCT04683042","title":"Fibromyalgia TENS in Physical Therapy Study (TIPS): an Embedded Pragmatic Clinical Trial","has_exemption":false,"start_date":"2021-01-22","completion_date":"2025-03-11","has_results":false,"results_due":true,"sponsor_name":"Kathleen Sluka","sponsor_slug":"kathleen-sluka","status":"reported-late","is_pact":false,"days_late":20},{"registry_id":"NCT05076838","publication_url":"https://clinicaltrials.gov/study/NCT05076838","title":"An Open-Label, Single-Dose, Pharmacokinetics Study of VALTOCO® With Open-Label Safety Period in Pediatric Subjects With Epilepsy","has_exemption":false,"start_date":"2021-11-08","completion_date":"2025-03-11","has_results":false,"results_due":true,"sponsor_name":"Neurelis, Inc.","sponsor_slug":"neurelis-inc","status":"overdue","is_pact":false,"days_late":42},{"registry_id":"NCT05405257","publication_url":"https://clinicaltrials.gov/study/NCT05405257","title":"Oxytocin Treatment for Chronic Pain in Hypermobile Ehlers-Danlos Syndrome","has_exemption":false,"start_date":"2022-05-13","completion_date":"2025-03-11","has_results":true,"results_due":true,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05432388","publication_url":"https://clinicaltrials.gov/study/NCT05432388","title":"A One Month, Investigator and Participant Blinded Study to Investigate the Efficacy and Safety of Remibrutinib (LOU064) at Multiple Dose Levels in Adult Participants With Peanut Allergy","has_exemption":false,"start_date":"2022-10-12","completion_date":"2025-03-11","has_results":false,"results_due":true,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06251024","publication_url":"https://clinicaltrials.gov/study/NCT06251024","title":"A Phase IIb, Randomized, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of an RSV Vaccine Candidate in Adult Participants 60 Years and Older","has_exemption":true,"start_date":"2024-04-02","completion_date":"2025-03-11","has_results":false,"results_due":false,"sponsor_name":"Sanofi Pasteur, a Sanofi Company","sponsor_slug":"sanofi-pasteur-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06111339","publication_url":"https://clinicaltrials.gov/study/NCT06111339","title":"Ketamine for the Treatment for Opioid Use Disorder and Suicidal Ideation in the Emergency Department","has_exemption":false,"start_date":"2024-06-14","completion_date":"2025-03-11","has_results":false,"results_due":true,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"reported-late","is_pact":false,"days_late":34},{"registry_id":"NCT03878095","publication_url":"https://clinicaltrials.gov/study/NCT03878095","title":"A Phase II Study of Olaparib and AZD6738 in Isocitrate Dehydrogenase (IDH) Mutant Solid Tumors","has_exemption":false,"start_date":"2020-01-30","completion_date":"2025-03-12","has_results":true,"results_due":true,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04369937","publication_url":"https://clinicaltrials.gov/study/NCT04369937","title":"Phase II Study Evaluating HPV-16 Vaccination (ISA101b) and Pembrolizumab Plus Cisplatin Chemoradiotherapy for \"Intermediate Risk\" HPV-16 Associated Head and Neck Squamous Cell Carcinoma (HNSCC)","has_exemption":false,"start_date":"2020-07-06","completion_date":"2025-03-12","has_results":false,"results_due":true,"sponsor_name":"Dan Zandberg","sponsor_slug":"dan-zandberg","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04264897","publication_url":"https://clinicaltrials.gov/study/NCT04264897","title":"Does Insulin Sensitivity Impact the Potential of Metformin to Slow Aging","has_exemption":true,"start_date":"2020-07-29","completion_date":"2025-03-12","has_results":false,"results_due":false,"sponsor_name":"Oklahoma Medical Research Foundation","sponsor_slug":"oklahoma-medical-research-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04379700","publication_url":"https://clinicaltrials.gov/study/NCT04379700","title":"Feasibility and Safety of Geniculate Artery Embolization for Treatment of Mild to Moderate Knee Osteoarthritis","has_exemption":false,"start_date":"2020-12-01","completion_date":"2025-03-12","has_results":true,"results_due":true,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04718896","publication_url":"https://clinicaltrials.gov/study/NCT04718896","title":"A Multicenter, Open-Label, Randomized Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis","has_exemption":false,"start_date":"2021-04-06","completion_date":"2025-03-12","has_results":false,"results_due":true,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05113251","publication_url":"https://clinicaltrials.gov/study/NCT05113251","title":"A Phase 3 Open-label Trial of Neoadjuvant Trastuzumab Deruxtecan (T-DXd) Monotherapy or T-DXd Followed by THP Compared to ddAC-THP in Participants With High-risk HER2-positive Early-stage Breast Cancer (DESTINY-Breast11)","has_exemption":false,"start_date":"2021-10-25","completion_date":"2025-03-12","has_results":false,"results_due":true,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05138757","publication_url":"https://clinicaltrials.gov/study/NCT05138757","title":"Fiber Supplementation In Children With Peanut Allergy On Oral Immunotherapy: A Randomized Controlled Pilot Study","has_exemption":false,"start_date":"2021-11-30","completion_date":"2025-03-12","has_results":true,"results_due":true,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05315414","publication_url":"https://clinicaltrials.gov/study/NCT05315414","title":"An Open, Prospective, Multicenter Investigation to Evaluate the Clinical Outcome of PrimeTaper EV Implant in Extraction Sockets and Healed Ridges - A 5 Year Follow-up","has_exemption":false,"start_date":"2022-05-03","completion_date":"2025-03-12","has_results":false,"results_due":true,"sponsor_name":"Dentsply Sirona Implants and Consumables","sponsor_slug":"dentsply-sirona-implants-and-consumables","status":"overdue","is_pact":false,"days_late":41},{"registry_id":"NCT05824767","publication_url":"https://clinicaltrials.gov/study/NCT05824767","title":"DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) Pilot: Serum Biomarkers to Predict Response to Angiotensin II vs. Standard-of-care Vasopressor Therapy in the Treatment of Septic Shock, a Randomized Controlled Pilot Trial","has_exemption":false,"start_date":"2023-04-17","completion_date":"2025-03-12","has_results":false,"results_due":true,"sponsor_name":"University of New Mexico","sponsor_slug":"university-of-new-mexico","status":"overdue","is_pact":false,"days_late":41},{"registry_id":"NCT05930067","publication_url":"https://clinicaltrials.gov/study/NCT05930067","title":"Continuation of Patient Follow-up to 2 Years for the Pinnacle RSA and Pinnacle DM RSA Clinical Trials","has_exemption":false,"start_date":"2023-05-02","completion_date":"2025-03-12","has_results":false,"results_due":true,"sponsor_name":"Canadian Radiostereometric Analysis Network","sponsor_slug":"canadian-radiostereometric-analysis-network","status":"overdue","is_pact":false,"days_late":41},{"registry_id":"NCT05504811","publication_url":"https://clinicaltrials.gov/study/NCT05504811","title":"FitMi AD: a Safe and Motivating Computer-guided Exercise System for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease","has_exemption":false,"start_date":"2023-09-08","completion_date":"2025-03-12","has_results":false,"results_due":true,"sponsor_name":"Flint Rehabilitation Devices, LLC","sponsor_slug":"flint-rehabilitation-devices-llc","status":"overdue","is_pact":false,"days_late":41},{"registry_id":"NCT05759481","publication_url":"https://clinicaltrials.gov/study/NCT05759481","title":"Prevention of Post-Operative Nausea and Vomiting With Propofol Infusion","has_exemption":false,"start_date":"2024-02-01","completion_date":"2025-03-12","has_results":false,"results_due":true,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06539715","publication_url":"https://clinicaltrials.gov/study/NCT06539715","title":"Comparison of Visual Field Assessments Between Three Perimeters","has_exemption":false,"start_date":"2024-11-18","completion_date":"2025-03-12","has_results":false,"results_due":true,"sponsor_name":"Gainesville Eye Associates","sponsor_slug":"gainesville-eye-associates","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT00200200","publication_url":"https://clinicaltrials.gov/study/NCT00200200","title":"Randomized Ph II Study of Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With IV Systemic Chemo With/Without Bevacizumab (mAB to Vascular Endothelial Growth Factor-A) in Patients With Resected Hepatic Metastases From Colorectal Cancer","has_exemption":false,"start_date":"2004-11-19","completion_date":"2025-03-13","has_results":false,"results_due":true,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02548559","publication_url":"https://clinicaltrials.gov/study/NCT02548559","title":"Sublingual Cannabidiol for Anxiety","has_exemption":false,"start_date":"2018-08-14","completion_date":"2025-03-13","has_results":true,"results_due":true,"sponsor_name":"Staci Gruber, Ph.D.","sponsor_slug":"staci-gruber-phd","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04502095","publication_url":"https://clinicaltrials.gov/study/NCT04502095","title":"Does Prophylactic Antibiotic Decrease the Rate of Urinary Tract Infection After Robot Assisted Radical Cystectomy","has_exemption":false,"start_date":"2020-09-02","completion_date":"2025-03-13","has_results":false,"results_due":true,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"overdue","is_pact":false,"days_late":40},{"registry_id":"NCT04980482","publication_url":"https://clinicaltrials.gov/study/NCT04980482","title":"A Randomized, Open-Label, Multicenter Study Investigating AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a Treatment in Subjects With Chronic Hepatitis B Infection","has_exemption":false,"start_date":"2021-10-29","completion_date":"2025-03-13","has_results":false,"results_due":true,"sponsor_name":"Arbutus Biopharma Corporation","sponsor_slug":"arbutus-biopharma-corporation","status":"reported-late","is_pact":false,"days_late":27},{"registry_id":"NCT05135286","publication_url":"https://clinicaltrials.gov/study/NCT05135286","title":"Multicenter, Double-Masked, Randomized, Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF Topical Ophthalmic Solution With Emmetropic Phakic and Pseudophakic Presbyopia","has_exemption":false,"start_date":"2022-03-15","completion_date":"2025-03-13","has_results":false,"results_due":true,"sponsor_name":"Visus Therapeutics","sponsor_slug":"visus-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05092516","publication_url":"https://clinicaltrials.gov/study/NCT05092516","title":"Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Cognitive Post-acute Sequelae of COVID-19 (PASC)","has_exemption":false,"start_date":"2022-06-07","completion_date":"2025-03-13","has_results":false,"results_due":true,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05695248","publication_url":"https://clinicaltrials.gov/study/NCT05695248","title":"A Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of STAR-0215 in Participants With Hereditary Angioedema (The ALPHA-STAR Trial)","has_exemption":false,"start_date":"2023-02-21","completion_date":"2025-03-13","has_results":false,"results_due":true,"sponsor_name":"Astria Therapeutics, Inc.","sponsor_slug":"astria-therapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05875974","publication_url":"https://clinicaltrials.gov/study/NCT05875974","title":"A Prospective, Open-Label, Single-Arm, Multicenter Study to Evaluate the Effect of Low-Sodium Oxybate Oral Solution (XYWAV) on Sleepiness, Polysomnography, and Functional Outcomes in Adult Participants Aged 18 to 75 Years With Idiopathic Hypersomnia or Narcolepsy","has_exemption":false,"start_date":"2023-07-27","completion_date":"2025-03-13","has_results":false,"results_due":true,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05997290","publication_url":"https://clinicaltrials.gov/study/NCT05997290","title":"A PHASE 2/3 PROTOCOL TO INVESTIGATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF BNT162b2 RNA-BASED VACCINE CANDIDATES FOR SARS-CoV-2 NEW VARIANTS IN HEALTHY INDIVIDUALS","has_exemption":false,"start_date":"2023-08-10","completion_date":"2025-03-13","has_results":false,"results_due":true,"sponsor_name":"Biontech SE","sponsor_slug":"biontech-se","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06939517","publication_url":"https://clinicaltrials.gov/study/NCT06939517","title":"Antiemetic Effect of Acupressure Wristbands for GLP-1RA Related Nausea","has_exemption":false,"start_date":"2024-02-01","completion_date":"2025-03-13","has_results":false,"results_due":true,"sponsor_name":"Florencia Ziemke","sponsor_slug":"florencia-ziemke","status":"overdue","is_pact":false,"days_late":40},{"registry_id":"NCT06585202","publication_url":"https://clinicaltrials.gov/study/NCT06585202","title":"A Phase 2a Open-label Study to Investigate the Safety, Tolerability, Pharmacokinetics, Efficacy, and Pharmacodynamics of ATI-2138 Administered Over 12 Weeks in Participants With Moderate to Severe Atopic Dermatitis","has_exemption":true,"start_date":"2024-08-19","completion_date":"2025-03-13","has_results":false,"results_due":false,"sponsor_name":"Aclaris Therapeutics, Inc.","sponsor_slug":"aclaris-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06572449","publication_url":"https://clinicaltrials.gov/study/NCT06572449","title":"A Phase 3b, Open-label, Multicenter, Two-Period, Slow-titration and Food Effect Study to Assess the Safety and Efficacy of KarXT in Participants With DSM-5 Schizophrenia","has_exemption":false,"start_date":"2024-10-28","completion_date":"2025-03-13","has_results":false,"results_due":true,"sponsor_name":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","sponsor_slug":"karuna-therapeutics-inc-a-bristol-myers-squibb-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT00254423","publication_url":"https://clinicaltrials.gov/study/NCT00254423","title":"Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib (BMS-354825)","has_exemption":false,"start_date":"2005-11-08","completion_date":"2025-03-14","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03150004","publication_url":"https://clinicaltrials.gov/study/NCT03150004","title":"A Phase II Study of the Efficacy and Pharmacogenomics of Cladribine-based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)","has_exemption":false,"start_date":"2017-06-14","completion_date":"2025-03-14","has_results":true,"results_due":true,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03797391","publication_url":"https://clinicaltrials.gov/study/NCT03797391","title":"First-in-human, Phase I/II, Multicenter, Open-Label Study of EMB-01 in Patients With Advanced/Metastatic Solid Tumors","has_exemption":false,"start_date":"2018-12-13","completion_date":"2025-03-14","has_results":false,"results_due":true,"sponsor_name":"Shanghai EpimAb Biotherapeutics Co., Ltd.","sponsor_slug":"shanghai-epimab-biotherapeutics-co-ltd","status":"overdue","is_pact":false,"days_late":39},{"registry_id":"NCT04032418","publication_url":"https://clinicaltrials.gov/study/NCT04032418","title":"Randomized Phase II Study of Pembrolizumab 200mg every12 Weeks Versus Every 3 Weeks in NSCLC With Clinical Benefit to Pembrolizumab Monotherapy: Multicenter International Study","has_exemption":false,"start_date":"2020-08-13","completion_date":"2025-03-14","has_results":false,"results_due":true,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"overdue","is_pact":false,"days_late":39},{"registry_id":"NCT05254002","publication_url":"https://clinicaltrials.gov/study/NCT05254002","title":"A Parallel-group Treatment, Phase 2, Double-blind, Three-arm Study to Assess Efficacy and Safety of Finerenone Plus Empagliflozin Compared With Either Finerenone or Empagliflozin Alone in Participants With Chronic Kidney Disease and Type 2 Diabetes.","has_exemption":false,"start_date":"2022-06-23","completion_date":"2025-03-14","has_results":false,"results_due":true,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05007821","publication_url":"https://clinicaltrials.gov/study/NCT05007821","title":"A Phase II, Prospective, Randomized, Multicenter Trial to Evaluate the Efficacy and Safety/Tolerability of Two Linezolid Dosing Strategies in Combination With a Short Course Regimen for the Treatment of Drug-Resistant Pulmonary Tuberculosis","has_exemption":false,"start_date":"2022-08-11","completion_date":"2025-03-14","has_results":false,"results_due":true,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05287113","publication_url":"https://clinicaltrials.gov/study/NCT05287113","title":"A Randomized, Double-Blind, Multicenter, Phase 2 Study of Retifanlimab in Combination With INCAGN02385 (Anti-LAG-3) and INCAGN02390 (Anti-TIM-3) as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck","has_exemption":false,"start_date":"2022-11-14","completion_date":"2025-03-14","has_results":true,"results_due":true,"sponsor_name":"Incyte Biosciences International Sàrl","sponsor_slug":"incyte-biosciences-international-sarl","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05961527","publication_url":"https://clinicaltrials.gov/study/NCT05961527","title":"An Open-Label Feasibility and Safety Study of MDMA-Assisted Group Therapy for the Treatment of Posttraumatic Stress Disorder in Veterans","has_exemption":false,"start_date":"2023-10-01","completion_date":"2025-03-14","has_results":false,"results_due":true,"sponsor_name":"Portland VA Research Foundation, Inc","sponsor_slug":"portland-va-research-foundation-inc","status":"overdue","is_pact":false,"days_late":39},{"registry_id":"NCT06308614","publication_url":"https://clinicaltrials.gov/study/NCT06308614","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled Proof-of-Concept Study to Evaluate the Efficacy and Safety of Estetrol in Postmenopausal Subjects With Female Sexual Arousal Disorder","has_exemption":false,"start_date":"2024-01-29","completion_date":"2025-03-14","has_results":false,"results_due":true,"sponsor_name":"Estetra","sponsor_slug":"estetra","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04325789","publication_url":"https://clinicaltrials.gov/study/NCT04325789","title":"A Prospective Randomized Multicenter Evaluation of Rotator Cuff Healing Using a Nanofiber Scaffold in Patients Greater Than 55 Years","has_exemption":false,"start_date":"2020-06-29","completion_date":"2025-03-15","has_results":false,"results_due":true,"sponsor_name":"Atreon Orthopedics","sponsor_slug":"atreon-orthopedics","status":"overdue","is_pact":false,"days_late":38},{"registry_id":"NCT05957887","publication_url":"https://clinicaltrials.gov/study/NCT05957887","title":"Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients","has_exemption":false,"start_date":"2022-04-15","completion_date":"2025-03-15","has_results":false,"results_due":true,"sponsor_name":"Mohamed Nabil Elkholy","sponsor_slug":"mohamed-nabil-elkholy","status":"overdue","is_pact":false,"days_late":38},{"registry_id":"NCT04078555","publication_url":"https://clinicaltrials.gov/study/NCT04078555","title":"A Randomized, Double-Blind, Placebo-controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of ENERGI-F703 GEL in Subjects With Venous Leg Ulcer (VLU)","has_exemption":false,"start_date":"2022-07-26","completion_date":"2025-03-15","has_results":false,"results_due":true,"sponsor_name":"Energenesis Biomedical Co., Ltd.","sponsor_slug":"energenesis-biomedical-co-ltd","status":"overdue","is_pact":false,"days_late":38},{"registry_id":"NCT05276258","publication_url":"https://clinicaltrials.gov/study/NCT05276258","title":"A Randomized Controlled Trial of cryoSPHERE (CRYOS/CRYOS-L) Ablation of Intercostal Nerves for Post-Operative Pain Management in Opioid-Tolerant Patients Undergoing Robotic-Assisted Thoracoscopic Surgery","has_exemption":false,"start_date":"2023-02-01","completion_date":"2025-03-15","has_results":false,"results_due":true,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"overdue","is_pact":false,"days_late":38},{"registry_id":"NCT05874037","publication_url":"https://clinicaltrials.gov/study/NCT05874037","title":"Fluvoxamine as a Treatment for Long COVID-19: A Randomized Placebo Controlled Trial","has_exemption":false,"start_date":"2023-05-15","completion_date":"2025-03-15","has_results":false,"results_due":true,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06111131","publication_url":"https://clinicaltrials.gov/study/NCT06111131","title":"A Randomized Controlled Trial to Demonstrate the Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures for Diagnosis and Treatment in the Small Intestine","has_exemption":false,"start_date":"2024-01-15","completion_date":"2025-03-15","has_results":false,"results_due":true,"sponsor_name":"Aspero Medical, Inc.","sponsor_slug":"aspero-medical-inc","status":"overdue","is_pact":false,"days_late":38},{"registry_id":"NCT06154265","publication_url":"https://clinicaltrials.gov/study/NCT06154265","title":"Default vs As-Needed Intraoperative Transesophageal Echocardiography (TEE) in Low-Risk Isolated Coronary Artery Bypass Graft (CABG) Surgery: A Randomized Controlled Trial","has_exemption":false,"start_date":"2024-01-22","completion_date":"2025-03-15","has_results":false,"results_due":true,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06720467","publication_url":"https://clinicaltrials.gov/study/NCT06720467","title":"Role of Immunotherapy in the Treatment of Eyelid Viral Papilloma","has_exemption":false,"start_date":"2024-06-11","completion_date":"2025-03-15","has_results":false,"results_due":true,"sponsor_name":"Zagazig University","sponsor_slug":"zagazig-university","status":"overdue","is_pact":false,"days_late":38},{"registry_id":"NCT06504602","publication_url":"https://clinicaltrials.gov/study/NCT06504602","title":"Pain Elimination and Anxiety Control Through Experiential Virtual Reality","has_exemption":false,"start_date":"2024-09-01","completion_date":"2025-03-15","has_results":false,"results_due":true,"sponsor_name":"Children's Hospital Los Angeles","sponsor_slug":"childrens-hospital-los-angeles","status":"overdue","is_pact":false,"days_late":38},{"registry_id":"NCT07019805","publication_url":"https://clinicaltrials.gov/study/NCT07019805","title":"Risk Factors for Post-Induction Hypotension Following General Anesthesia in Geriatric Patients Undergoing Elective Non-Cardiac Surgery : A Prospective Study","has_exemption":false,"start_date":"2024-09-01","completion_date":"2025-03-15","has_results":false,"results_due":true,"sponsor_name":"Indonesia University","sponsor_slug":"indonesia-university","status":"overdue","is_pact":false,"days_late":38},{"registry_id":"NCT06806202","publication_url":"https://clinicaltrials.gov/study/NCT06806202","title":"Comparative Evaluation of Anesthetic Efficacy of Warm and Conventional 2% Lignocaine for the Success of Inferior Alveolar Nerve Block (IANB) in Mandibular Permanent Molars: A Randomized Controlled Clinical Trial","has_exemption":false,"start_date":"2024-12-15","completion_date":"2025-03-15","has_results":false,"results_due":true,"sponsor_name":"Armed Forces Institute of Dentistry, Pakistan","sponsor_slug":"armed-forces-institute-of-dentistry-pakistan","status":"overdue","is_pact":false,"days_late":38},{"registry_id":"NCT06844279","publication_url":"https://clinicaltrials.gov/study/NCT06844279","title":"Geriatrik Hasta Grubunda Anestezi Derinliği Monitörizasyonlarının Postoperatif Derlenme ve Bilişsel Fonksiyonlara Etkileri","has_exemption":false,"start_date":"2025-01-10","completion_date":"2025-03-15","has_results":false,"results_due":true,"sponsor_name":"Aslıhan Güleç","sponsor_slug":"aslhan-gulec","status":"overdue","is_pact":false,"days_late":38},{"registry_id":"NCT06746038","publication_url":"https://clinicaltrials.gov/study/NCT06746038","title":"Evaluation of Extended Wear Hearing Aid for Mild Hearing Loss","has_exemption":false,"start_date":"2025-01-15","completion_date":"2025-03-15","has_results":false,"results_due":true,"sponsor_name":"Sonova AG","sponsor_slug":"sonova-ag","status":"overdue","is_pact":false,"days_late":38},{"registry_id":"NCT04673175","publication_url":"https://clinicaltrials.gov/study/NCT04673175","title":"A Pilot Study of Ceftolozane-Tazobactam in Conjunction With Rapid Molecular Diagnosis for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation","has_exemption":false,"start_date":"2023-01-10","completion_date":"2025-03-16","has_results":true,"results_due":true,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06773013","publication_url":"https://clinicaltrials.gov/study/NCT06773013","title":"Safety and Effectiveness of Sonu Acoustic Resonance Therapy for the Treatment of Pediatric Patients With Moderate to Severe Nasal Congestion.","has_exemption":false,"start_date":"2025-01-09","completion_date":"2025-03-16","has_results":false,"results_due":true,"sponsor_name":"Third Wave Therapeutics","sponsor_slug":"third-wave-therapeutics","status":"overdue","is_pact":false,"days_late":37},{"registry_id":"NCT02348749","publication_url":"https://clinicaltrials.gov/study/NCT02348749","title":"A Phase I/IIA Study of 18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies","has_exemption":false,"start_date":"2015-01-31","completion_date":"2025-03-17","has_results":false,"results_due":true,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03819322","publication_url":"https://clinicaltrials.gov/study/NCT03819322","title":"Transplantation of Livers of Hepatitis C (HCV) Seropositive Donors to HCV Seronegative Recipients With Subsequent Therapy With Sofosbuvir/Velpatasvir (Epclusa®)","has_exemption":false,"start_date":"2019-08-15","completion_date":"2025-03-17","has_results":false,"results_due":true,"sponsor_name":"Fernanda P Silveira, MD, MS","sponsor_slug":"fernanda-p-silveira-md-ms","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04216563","publication_url":"https://clinicaltrials.gov/study/NCT04216563","title":"Phase II Study of Dual Targeting of BCR-ABL1 by Adding the Allosteric Inhibitor ABL001 in Patients With Chronic Myeloid Leukemia (CML) and Minimal Residual Disease (MRD) While on Therapy With Tyrosine Kinase Inhibitors","has_exemption":false,"start_date":"2020-07-29","completion_date":"2025-03-17","has_results":true,"results_due":true,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04327817","publication_url":"https://clinicaltrials.gov/study/NCT04327817","title":"A Prospective Single Arm Pilot Study to Investigate the Dynamic Brain and Multifidus Muscle Imaging in Response to Multifidus Stimulation in Patients With Low Back Pain Undergoing Reactiv8 Implant","has_exemption":false,"start_date":"2021-08-19","completion_date":"2025-03-17","has_results":false,"results_due":true,"sponsor_name":"Barts & The London NHS Trust","sponsor_slug":"barts-the-london-nhs-trust","status":"overdue","is_pact":false,"days_late":36},{"registry_id":"NCT05324449","publication_url":"https://clinicaltrials.gov/study/NCT05324449","title":"Epidiolex® For The Treatment Of Anxiety Comorbidity in Refractory Pediatric Epilepsy","has_exemption":false,"start_date":"2022-04-05","completion_date":"2025-03-17","has_results":false,"results_due":true,"sponsor_name":"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.","sponsor_slug":"hugo-w-moser-research-institute-at-kennedy-krieger-inc","status":"overdue","is_pact":false,"days_late":36},{"registry_id":"NCT05428033","publication_url":"https://clinicaltrials.gov/study/NCT05428033","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Determine the Efficacy and Safety of Once Daily Centanafadine Capsules for the Treatment of Children With Attention-deficit/Hyperactivity Disorder (ADHD)","has_exemption":true,"start_date":"2022-07-11","completion_date":"2025-03-17","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05881135","publication_url":"https://clinicaltrials.gov/study/NCT05881135","title":"Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET)","has_exemption":false,"start_date":"2023-06-06","completion_date":"2025-03-17","has_results":false,"results_due":true,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"overdue","is_pact":false,"days_late":36},{"registry_id":"NCT05680727","publication_url":"https://clinicaltrials.gov/study/NCT05680727","title":"The Role of Individualized Functional Connectivity Targeting in Accelerated Intelligent Neuromodulation Therapy (AINT) for Depression","has_exemption":false,"start_date":"2023-07-15","completion_date":"2025-03-17","has_results":false,"results_due":true,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05799755","publication_url":"https://clinicaltrials.gov/study/NCT05799755","title":"Nintedanib Plus Standard of Care Immunosuppression Versus Standard of Care Immunosuppression Alone in Patients With Progressive Fibrotic Myositis Associated - Interstitial Lung Disease: A Randomized, Double-Blind, Exploratory Trial","has_exemption":true,"start_date":"2023-08-01","completion_date":"2025-03-17","has_results":false,"results_due":false,"sponsor_name":"Rohit Aggarwal, MD","sponsor_slug":"rohit-aggarwal-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05938699","publication_url":"https://clinicaltrials.gov/study/NCT05938699","title":"Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution - A Double-Masked, Placebo-Controlled, Phase 3b Clinical Trial (Whistler)","has_exemption":true,"start_date":"2023-12-12","completion_date":"2025-03-17","has_results":false,"results_due":false,"sponsor_name":"Nicox Ophthalmics, Inc.","sponsor_slug":"nicox-ophthalmics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06351293","publication_url":"https://clinicaltrials.gov/study/NCT06351293","title":"A Randomized, Split-face Clinical Study on Comparative Analysis of Two Hyaluronic Acid Fillers for Nasolabial Fold Correction","has_exemption":false,"start_date":"2024-02-21","completion_date":"2025-03-17","has_results":false,"results_due":true,"sponsor_name":"Galderma R&D","sponsor_slug":"galderma-rd","status":"overdue","is_pact":false,"days_late":36},{"registry_id":"NCT01862315","publication_url":"https://clinicaltrials.gov/study/NCT01862315","title":"A Phase II Study of Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)","has_exemption":false,"start_date":"2013-05-31","completion_date":"2025-03-18","has_results":false,"results_due":true,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT04586426","publication_url":"https://clinicaltrials.gov/study/NCT04586426","title":"A Phase 1b/2 Dose Escalation and Expansion Study of the Combination of the Bispecific T Cell Redirection Antibodies Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2020-12-15","completion_date":"2025-03-18","has_results":false,"results_due":true,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04956120","publication_url":"https://clinicaltrials.gov/study/NCT04956120","title":"Effect of Citrate Dialysate on Vascular Calcification","has_exemption":false,"start_date":"2021-06-02","completion_date":"2025-03-18","has_results":false,"results_due":true,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04963075","publication_url":"https://clinicaltrials.gov/study/NCT04963075","title":"Non-Invasive Multisensory Rehabilitation of Hemianopia","has_exemption":true,"start_date":"2021-09-22","completion_date":"2025-03-18","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05109234","publication_url":"https://clinicaltrials.gov/study/NCT05109234","title":"A Multicenter, Open-Label, Single-Arm Study to Evaluate Long-Term Safety, Tolerability, and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy","has_exemption":false,"start_date":"2022-03-30","completion_date":"2025-03-18","has_results":true,"results_due":true,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05425056","publication_url":"https://clinicaltrials.gov/study/NCT05425056","title":"A Phase 3, Prospective, Randomized, Multicenter, Single-blind, Controlled Study Evaluating Arteriovenous Fistula Outcomes With and Without a Perivascular Sirolimus Eluting Collagen Implant (The ACCESS 2 Trial)","has_exemption":false,"start_date":"2022-08-26","completion_date":"2025-03-18","has_results":false,"results_due":true,"sponsor_name":"Vascular Therapies, Inc.","sponsor_slug":"vascular-therapies-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05543252","publication_url":"https://clinicaltrials.gov/study/NCT05543252","title":"A Dose-Blinded Extension Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of UCB0599 in Study Participants With Parkinson's Disease","has_exemption":false,"start_date":"2022-08-29","completion_date":"2025-03-18","has_results":true,"results_due":true,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05496868","publication_url":"https://clinicaltrials.gov/study/NCT05496868","title":"Phase 2, Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Assess Efficacy and Safety of Reparixin as add-on Therapy to SoC in Acute Respiratory Distress Syndrome (RESPIRATIO)","has_exemption":false,"start_date":"2022-12-06","completion_date":"2025-03-18","has_results":false,"results_due":true,"sponsor_name":"Dompé Farmaceutici S.p.A","sponsor_slug":"dompe-farmaceutici-spa","status":"reported-late","is_pact":false,"days_late":20},{"registry_id":"NCT05774756","publication_url":"https://clinicaltrials.gov/study/NCT05774756","title":"A Phase 3, Double Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Setmelanotide in Patients With Acquired Hypothalamic Obesity","has_exemption":false,"start_date":"2023-04-26","completion_date":"2025-03-18","has_results":false,"results_due":true,"sponsor_name":"Rhythm Pharmaceuticals, Inc.","sponsor_slug":"rhythm-pharmaceuticals-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05889156","publication_url":"https://clinicaltrials.gov/study/NCT05889156","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled 28- Day Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of NST-1024 400 mg BID Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects","has_exemption":false,"start_date":"2023-06-30","completion_date":"2025-03-18","has_results":false,"results_due":true,"sponsor_name":"NorthSea Therapeutics B.V.","sponsor_slug":"northsea-therapeutics-bv","status":"overdue","is_pact":false,"days_late":35},{"registry_id":"NCT06056011","publication_url":"https://clinicaltrials.gov/study/NCT06056011","title":"TIMMY3 80601-2-56:2017 + A1 2018 Clinical Accuracy Study","has_exemption":false,"start_date":"2024-02-19","completion_date":"2025-03-18","has_results":true,"results_due":true,"sponsor_name":"Baxter Healthcare Corporation","sponsor_slug":"baxter-healthcare-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06261619","publication_url":"https://clinicaltrials.gov/study/NCT06261619","title":"A Comparative Trial Between Sotair® Device Attached to Manual Resuscitator Versus Manual Ventilation Alone in Patients Undergoing Non-emergent Surgery With General Anesthesia: A Prospective Randomized Cross-over Clinical Trial","has_exemption":false,"start_date":"2024-05-09","completion_date":"2025-03-18","has_results":false,"results_due":true,"sponsor_name":"Rhode Island Hospital","sponsor_slug":"rhode-island-hospital","status":"overdue","is_pact":false,"days_late":35},{"registry_id":"NCT03712878","publication_url":"https://clinicaltrials.gov/study/NCT03712878","title":"A 2 Step Approach to Matched Related Hematopoietic Stem Cell Transplantation for Patients With Hematological Malignancies-5+5 Dosing","has_exemption":false,"start_date":"2018-09-19","completion_date":"2025-03-19","has_results":false,"results_due":true,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03789591","publication_url":"https://clinicaltrials.gov/study/NCT03789591","title":"Hydroxyurea Optimization Through Precision Study (HOPS): A Prospective, Multi-center, Randomized Trial of Personalized, Pharmacokinetics-guided Dosing of Hydroxyurea Versus Standard Weight-based Dosing for Children With Sickle Cell Anemia.","has_exemption":false,"start_date":"2019-01-17","completion_date":"2025-03-19","has_results":false,"results_due":true,"sponsor_name":"Lifespan","sponsor_slug":"lifespan","status":"overdue","is_pact":false,"days_late":34},{"registry_id":"NCT03534934","publication_url":"https://clinicaltrials.gov/study/NCT03534934","title":"CT-Based Modeling of Bone Micro-Architecture and Fracture-Risk in COPD","has_exemption":true,"start_date":"2019-02-26","completion_date":"2025-03-19","has_results":false,"results_due":false,"sponsor_name":"Punam K Saha","sponsor_slug":"punam-k-saha","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03815019","publication_url":"https://clinicaltrials.gov/study/NCT03815019","title":"iKanEat: A Randomized-controlled, Multi-center Trial of Megestrol for Chronic Oral Food Refusal in Children 9 Months to 9 Years 0 Months of Age","has_exemption":false,"start_date":"2019-08-15","completion_date":"2025-03-19","has_results":true,"results_due":true,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04736849","publication_url":"https://clinicaltrials.gov/study/NCT04736849","title":"Pilot Study of Epidural and Dorsal Root Stimulation in Humans With Spinal Cord Injury","has_exemption":false,"start_date":"2021-09-24","completion_date":"2025-03-19","has_results":false,"results_due":true,"sponsor_name":"Peter J. Grahn, Ph.D.","sponsor_slug":"peter-j-grahn-phd","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05145413","publication_url":"https://clinicaltrials.gov/study/NCT05145413","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia","has_exemption":false,"start_date":"2021-11-12","completion_date":"2025-03-19","has_results":false,"results_due":true,"sponsor_name":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","sponsor_slug":"karuna-therapeutics-inc-a-bristol-myers-squibb-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05180799","publication_url":"https://clinicaltrials.gov/study/NCT05180799","title":"A Phase 1/2 Study of BA3071 in Patients With Solid Tumors","has_exemption":false,"start_date":"2022-08-03","completion_date":"2025-03-19","has_results":false,"results_due":true,"sponsor_name":"BioAtla, Inc.","sponsor_slug":"bioatla-inc","status":"overdue","is_pact":false,"days_late":34},{"registry_id":"NCT05769582","publication_url":"https://clinicaltrials.gov/study/NCT05769582","title":"Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients, a Randomized Phase II/III Study, Double-blind and Placebo-controlled","has_exemption":false,"start_date":"2023-04-10","completion_date":"2025-03-19","has_results":false,"results_due":true,"sponsor_name":"Memo Therapeutics AG","sponsor_slug":"memo-therapeutics-ag","status":"overdue","is_pact":false,"days_late":34},{"registry_id":"NCT06313632","publication_url":"https://clinicaltrials.gov/study/NCT06313632","title":"A Triple-Blind Randomized Controlled Trial of Erector Spinae Plane Block With Bupivacaine Versus Placebo in Patients Undergoing Medical Thoracoscopy","has_exemption":false,"start_date":"2024-03-28","completion_date":"2025-03-19","has_results":false,"results_due":true,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"overdue","is_pact":false,"days_late":34},{"registry_id":"NCT06445504","publication_url":"https://clinicaltrials.gov/study/NCT06445504","title":"A Prospective, Multi-center, Single-arm Study of the Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Inguinal and Ventral Hernia Repair Surgery (Enable Hernia)","has_exemption":false,"start_date":"2024-04-08","completion_date":"2025-03-19","has_results":false,"results_due":true,"sponsor_name":"Medtronic - MITG","sponsor_slug":"medtronic-mitg","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06311292","publication_url":"https://clinicaltrials.gov/study/NCT06311292","title":"Pilot Study of Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis","has_exemption":false,"start_date":"2024-05-29","completion_date":"2025-03-19","has_results":false,"results_due":true,"sponsor_name":"Daniel J. Weiner","sponsor_slug":"daniel-j-weiner","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06438575","publication_url":"https://clinicaltrials.gov/study/NCT06438575","title":"Point of Care Diagnosis of Vaginal Infections to Ensure Accurate Treatment: (PAT Study)","has_exemption":false,"start_date":"2024-06-16","completion_date":"2025-03-19","has_results":true,"results_due":true,"sponsor_name":"Sharon L Hillier","sponsor_slug":"sharon-l-hillier","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06390137","publication_url":"https://clinicaltrials.gov/study/NCT06390137","title":"The Immunomodulatory Effects of Frequency Specific Microcurrent In Obese Osteoarthritic Adults","has_exemption":false,"start_date":"2025-03-05","completion_date":"2025-03-19","has_results":false,"results_due":true,"sponsor_name":"Nova Southeastern University","sponsor_slug":"nova-southeastern-university","status":"overdue","is_pact":false,"days_late":34},{"registry_id":"NCT02659215","publication_url":"https://clinicaltrials.gov/study/NCT02659215","title":"A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority of Hyalofast® With BMAC in the Treatment of Articular Knee Cartilage Defect Lesions in Comparison to Control","has_exemption":true,"start_date":"2015-12-31","completion_date":"2025-03-20","has_results":false,"results_due":false,"sponsor_name":"Anika Therapeutics, Inc.","sponsor_slug":"anika-therapeutics-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02699697","publication_url":"https://clinicaltrials.gov/study/NCT02699697","title":"A Prospective Randomized Phase II Study of 1 vs 2 Fractions of Palliative Radiation Therapy for Patients With Symptomatic Bone Metastasis","has_exemption":false,"start_date":"2016-05-31","completion_date":"2025-03-20","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03867084","publication_url":"https://clinicaltrials.gov/study/NCT03867084","title":"A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma and Complete Radiological Response After Surgical Resection or Local Ablation (KEYNOTE-937)","has_exemption":false,"start_date":"2019-05-28","completion_date":"2025-03-20","has_results":false,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04609904","publication_url":"https://clinicaltrials.gov/study/NCT04609904","title":"A Randomized, Double-Blind, Double Dummy, Parallel Group, Multicenter Variable Length Study to Assess the Efficacy and Safety of PT010 Relative to PT009 and Symbicort® in Adult and Adolescent Participants With Inadequately Controlled Asthma","has_exemption":false,"start_date":"2021-03-01","completion_date":"2025-03-20","has_results":false,"results_due":true,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04691154","publication_url":"https://clinicaltrials.gov/study/NCT04691154","title":"A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety and Tolerability of Liposomal Treprostinil Inhalation Suspension (L606) in Subjects With Pulmonary Arterial Hypertension or Pulmonary Hypertension Associated With Interstitial Lung Disease","has_exemption":true,"start_date":"2021-08-01","completion_date":"2025-03-20","has_results":false,"results_due":false,"sponsor_name":"Liquidia Technologies, Inc.","sponsor_slug":"liquidia-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05549934","publication_url":"https://clinicaltrials.gov/study/NCT05549934","title":"A Pilot Study to Assess Safety and Biomarker Responses of Ritlecitinib (JAK3/TEC Inhibitor) in Cicatricial Alopecia","has_exemption":false,"start_date":"2022-12-15","completion_date":"2025-03-20","has_results":false,"results_due":true,"sponsor_name":"Emma Guttman","sponsor_slug":"emma-guttman","status":"overdue","is_pact":false,"days_late":33},{"registry_id":"NCT05681481","publication_url":"https://clinicaltrials.gov/study/NCT05681481","title":"An Open-label Extension Study of ARGX-113-2009 to Evaluate the Long Term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid","has_exemption":false,"start_date":"2023-03-22","completion_date":"2025-03-20","has_results":true,"results_due":true,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05963984","publication_url":"https://clinicaltrials.gov/study/NCT05963984","title":"An Open-label, Interventional, Multicenter, Randomized, Phase 2 Study of Fulvestrant With or Without Samuraciclib in Participants With Metastatic or Locally Advanced Hormone Receptor (HR) Positive and Human Epidermal Growth Factor Receptor (HER)2-Negative Breast Cancer (BC)","has_exemption":true,"start_date":"2023-11-16","completion_date":"2025-03-20","has_results":false,"results_due":false,"sponsor_name":"Carrick Therapeutics Limited","sponsor_slug":"carrick-therapeutics-limited","status":"ongoing","is_pact":false,"days_late":null}]}